_MEMBER_cluster_1_x_name,_LogP_cluster_1_x_name,GO,Description,_PATTERN_,_RANK_,GiniIndex
1,-3.1,GDP02344,Endometrioma,M1,1,0
1,-9,GO:0010763,positive regulation of fibroblast migration,M1,1,0
1,-6.1,GO:0060249,anatomical structure homeostasis,M1,1,0
1,-3.6,GO:0002792,negative regulation of peptide secretion,M1,1,0
1,-3,M257,PID EPHRINB REV PATHWAY,M1,1,0
1,-3.6,GO:0060443,mammary gland morphogenesis,M1,1,0
1,-4.4,GO:0033622,integrin activation,M1,1,0
1,-2.4,GO:1902807,negative regulation of cell cycle G1/S phase transition,M1,1,0
1,-2.6,R-HSA-202733,Cell surface interactions at the vascular wall,M1,1,0
1,-3.8,GO:0071805,potassium ion transmembrane transport,M1,1,0
1,-5.8,GO:2000628,regulation of miRNA metabolic process,M1,1,0
1,-7.1,GO:0051896,regulation of protein kinase B signaling,M1,1,0
1,-3.8,GO:0051926,negative regulation of calcium ion transport,M1,1,0
1,-5,WP2263,Androgen receptor network in prostate cancer,M1,1,0
1,-6.6,GO:0051146,striated muscle cell differentiation,M1,1,0
1,-6.1,GO:0002793,positive regulation of peptide secretion,M1,1,0
1,-5.8,GDP02342,Endometrial carcinoma,M1,1,0
1,-7.1,GO:0048738,cardiac muscle tissue development,M1,1,0
1,-3.7,GO:0009266,response to temperature stimulus,M1,1,0
1,-3.6,WP4217,Ebola virus infection in host,M1,1,0
1,-2.3,GO:0042269,regulation of natural killer cell mediated cytotoxicity,M1,1,0
1,-2.4,WP4312,Rett syndrome causing genes,M1,1,0
1,-12,GO:0033674,positive regulation of kinase activity,M1,1,0
1,-4.4,GO:0006814,sodium ion transport,M1,1,0
1,-5.1,M237,PID VEGFR1 2 PATHWAY,M1,1,0
1,-4,WP2857,Mesodermal commitment pathway,M1,1,0
1,-9.6,GO:0019725,cellular homeostasis,M1,1,0
1,-2.9,GDP01348,Clinodactyly,M1,1,0
1,-5.2,GO:1901342,regulation of vasculature development,M1,1,0
1,-13,GO:0032870,cellular response to hormone stimulus,M1,1,0
1,-2.2,GDP00622,Atrioventricular block,M1,1,0
1,-2.4,GO:0090311,regulation of protein deacetylation,M1,1,0
1,-2.9,M275,PID ALPHA SYNUCLEIN PATHWAY,M1,1,0
1,-3.1,GDP03396,Hypoalbuminemia,M1,1,0
1,-2.1,hsa04330,Notch signaling pathway,M1,1,0
1,-7.6,WP3915,Angiopoietin-like protein 8 regulatory pathway,M1,1,0
1,-11,GO:0031400,negative regulation of protein modification process,M1,1,0
1,-6,M33,PID GLYPICAN 1PATHWAY,M1,1,0
1,-3.6,GDP00922,Brittle diabetes mellitus,M1,1,0
1,-4,GO:1902305,regulation of sodium ion transmembrane transport,M1,1,0
1,-3.6,GDP06906,Syndactyly of fingers,M1,1,0
1,-4.8,hsa05100,Bacterial invasion of epithelial cells,M1,1,0
1,-6.2,GDP05413,Osteoporosis,M1,1,0
1,-4.2,GO:2001237,negative regulation of extrinsic apoptotic signaling pathway,M1,1,0
1,-10,R-HSA-382551,Transport of small molecules,M1,1,0
1,-4,M249,PID PI3KCI AKT PATHWAY,M1,1,0
1,-3.5,R-HSA-69231,Cyclin D associated events in G1,M1,1,0
1,-4.9,GO:0006909,phagocytosis,M1,1,0
1,-4,GDP03517,Hypothyroidism,M1,1,0
1,-2.4,GDP03326,Hyperlipidemia,M1,1,0
1,-2.3,hsa05231,Choline metabolism in cancer,M1,1,0
1,-4,WP289,Myometrial relaxation and contraction pathways,M1,1,0
1,-5.3,WP34,Ovarian infertility,M1,1,0
1,-2.3,GO:0010976,positive regulation of neuron projection development,M1,1,0
1,-3.8,GO:0043462,regulation of ATP-dependent activity,M1,1,0
1,-6.2,GO:0048771,tissue remodeling,M1,1,0
1,-2.9,GO:2001234,negative regulation of apoptotic signaling pathway,M1,1,0
1,-8.9,WP437,EGF/EGFR signaling pathway,M1,1,0
1,-4.1,GO:0097061,dendritic spine organization,M1,1,0
1,-3,GO:0060765,regulation of androgen receptor signaling pathway,M1,1,0
1,-4.9,GO:0000079,regulation of cyclin-dependent protein serine/threonine kinase activity,M1,1,0
1,-2,R-HSA-400206,Regulation of lipid metabolism by PPARalpha,M1,1,0
1,-3.9,GO:0051147,regulation of muscle cell differentiation,M1,1,0
1,-2.5,R-HSA-9013404,RAC2 GTPase cycle,M1,1,0
1,-4.1,GO:0046888,negative regulation of hormone secretion,M1,1,0
1,-4.2,GO:0017157,regulation of exocytosis,M1,1,0
1,-6.4,GO:0008585,female gonad development,M1,1,0
1,-8.9,GO:0051051,negative regulation of transport,M1,1,0
1,-5.1,GO:0048667,cell morphogenesis involved in neuron differentiation,M1,1,0
1,-10,GO:0090066,regulation of anatomical structure size,M1,1,0
1,-2.3,GO:0043279,response to alkaloid,M1,1,0
1,-2,GO:0090068,positive regulation of cell cycle process,M1,1,0
1,-2.7,GDP02956,HYPERTRICHOSIS,M1,1,0
1,-4.4,M125,PID IGF1 PATHWAY,M1,1,0
1,-3.5,hsa04621,NOD-like receptor signaling pathway,M1,1,0
1,-2.3,GDP03840,Jacksonian Seizure,M1,1,0
1,-4.1,M30,PID HDAC CLASSII PATHWAY,M1,1,0
1,-6.3,hsa04360,Axon guidance,M1,1,0
1,-2.6,GO:0022404,molting cycle process,M1,1,0
1,-4.2,GO:0002244,hematopoietic progenitor cell differentiation,M1,1,0
1,-2.8,GO:0050900,leukocyte migration,M1,1,0
1,-8.1,GO:0071901,negative regulation of protein serine/threonine kinase activity,M1,1,0
1,-6.4,GO:0048729,tissue morphogenesis,M1,1,0
1,-4.5,GO:0010874,regulation of cholesterol efflux,M1,1,0
1,-7.5,GO:0048858,cell projection morphogenesis,M1,1,0
1,-2.7,GO:0003231,cardiac ventricle development,M1,1,0
1,-3.6,GO:1904646,cellular response to amyloid-beta,M1,1,0
1,-2.2,GO:0000077,DNA damage checkpoint signaling,M1,1,0
1,-3.6,GO:0002088,lens development in camera-type eye,M1,1,0
1,-3.3,GO:0050982,detection of mechanical stimulus,M1,1,0
1,-2.4,GO:2001239,regulation of extrinsic apoptotic signaling pathway in absence of ligand,M1,1,0
1,-6.1,GO:0097659,nucleic acid-templated transcription,M1,1,0
1,-3.5,GO:0051169,nuclear transport,M1,1,0
1,-3,hsa05145,Toxoplasmosis,M1,1,0
1,-3,GO:0015849,organic acid transport,M1,1,0
1,-9.2,GDP03927,Kidney Disease,M1,1,0
1,-4.3,GO:0010565,regulation of cellular ketone metabolic process,M1,1,0
1,-11,GO:1901653,cellular response to peptide,M1,1,0
1,-3.1,GDP06512,Seronegative polyarthritis,M1,1,0
1,-3.1,GO:1901655,cellular response to ketone,M1,1,0
1,-3,GO:0007610,behavior,M1,1,0
1,-3.4,R-HSA-9758941,Gastrulation,M1,1,0
1,-3.4,GDP02229,Dysphagia,M1,1,0
1,-2,GO:0051101,regulation of DNA binding,M1,1,0
1,-8.2,WP2261,Glioblastoma signaling pathways,M1,1,0
1,-11,R-HSA-5684996,MAPK1/MAPK3 signaling,M1,1,0
1,-3.3,M122,PID IL2 1PATHWAY,M1,1,0
1,-6.8,R-HSA-9716542,"Signaling by Rho GTPases, Miro GTPases and RHOBTB3",M1,1,0
1,-2.1,R-HSA-181438,Toll Like Receptor 2 (TLR2) Cascade,M1,1,0
1,-4.3,GDP05071,Neuroblastoma,M1,1,0
1,-5.9,WP5036,Angiotensin II receptor type 1 pathway,M1,1,0
1,-9.3,hsa05226,Gastric cancer,M1,1,0
1,-3.3,R-HSA-2404192,Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R),M1,1,0
1,-6.6,GO:1903035,negative regulation of response to wounding,M1,1,0
1,-4,GDP02411,Epileptic encephalopathy,M1,1,0
1,-23,GO:0003018,vascular process in circulatory system,M1,1,0
1,-6.5,WP4963,p53 transcriptional gene network,M1,1,0
1,-2.2,GO:0002715,regulation of natural killer cell mediated immunity,M1,1,0
1,-2.4,GO:0071326,cellular response to monosaccharide stimulus,M1,1,0
1,-2.7,GO:0001942,hair follicle development,M1,1,0
1,-9.4,GO:0010232,vascular transport,M1,1,0
1,-2.5,GO:0006520,amino acid metabolic process,M1,1,0
1,-12,R-HSA-2219528,PI3K/AKT Signaling in Cancer,M1,1,0
1,-5.7,GO:0034284,response to monosaccharide,M1,1,0
1,-7.4,GDP04907,Myocardial Ischemia,M1,1,0
1,-2.3,R-HSA-202424,Downstream TCR signaling,M1,1,0
1,-2.4,GO:0016042,lipid catabolic process,M1,1,0
1,-5.1,GDP02392,Epilepsy,M1,1,0
1,-2.1,GDP03208,High palate,M1,1,0
1,-3.8,hsa01524,Platinum drug resistance,M1,1,0
1,-6.8,GO:0120039,plasma membrane bounded cell projection morphogenesis,M1,1,0
1,-6.2,GO:0030644,intracellular chloride ion homeostasis,M1,1,0
1,-4,hsa05221,Acute myeloid leukemia,M1,1,0
1,-2.8,hsa04935,"Growth hormone synthesis, secretion and action",M1,1,0
1,-6.2,GDP04174,Liver carcinoma,M1,1,0
1,-6.6,GO:0001542,ovulation from ovarian follicle,M1,1,0
1,-5.1,WP3303,RAC1/PAK1/p38/MMP2 pathway,M1,1,0
1,-2.1,R-HSA-1989781,PPARA activates gene expression,M1,1,0
1,-6,GO:0010875,positive regulation of cholesterol efflux,M1,1,0
1,-4.2,GO:0050671,positive regulation of lymphocyte proliferation,M1,1,0
1,-2.7,M229,PID P38 ALPHA BETA DOWNSTREAM PATHWAY,M1,1,0
1,-6,WP2034,Leptin signaling pathway,M1,1,0
1,-4.1,M143,PID IL2 PI3K PATHWAY,M1,1,0
1,-2.7,GDP04629,Micrognathism,M1,1,0
1,-9.6,hsa04371,Apelin signaling pathway,M1,1,0
1,-4.2,hsa04978,Mineral absorption,M1,1,0
1,-10,GO:0034329,cell junction assembly,M1,1,0
1,-2.7,GDP05525,Papillary Adenoma,M1,1,0
1,-2.8,GO:0045806,negative regulation of endocytosis,M1,1,0
1,-8.9,GO:0043269,regulation of monoatomic ion transport,M1,1,0
1,-3.9,GO:0031396,regulation of protein ubiquitination,M1,1,0
1,-7.4,GO:0007589,body fluid secretion,M1,1,0
1,-3.4,hsa04140,Autophagy - animal,M1,1,0
1,-3.5,WP2203,Thymic stromal lymphopoietin (TSLP) signaling pathway,M1,1,0
1,-2,GO:0045833,negative regulation of lipid metabolic process,M1,1,0
1,-7.2,WP363,Wnt signaling pathway,M1,1,0
1,-4.2,GO:0045428,regulation of nitric oxide biosynthetic process,M1,1,0
1,-6,hsa04010,MAPK signaling pathway,M1,1,0
1,-2.1,GO:0097553,calcium ion transmembrane import into cytosol,M1,1,0
1,-2.1,GO:0031032,actomyosin structure organization,M1,1,0
1,-5.2,GDP01265,Cholestasis,M1,1,0
1,-2.7,GO:0051385,response to mineralocorticoid,M1,1,0
1,-5.5,CORUM:753,UTM-SGCE-DAG1-CAV1-NOS3 complex,M1,1,0
1,-5.1,GO:0071902,positive regulation of protein serine/threonine kinase activity,M1,1,0
1,-2.9,GDP06607,Skeletal Dysplasia,M1,1,0
1,-9.4,WP3932,Focal adhesion: PI3K-Akt-mTOR-signaling pathway,M1,1,0
1,-3,WP4905,1q21.1 copy number variation syndrome,M1,1,0
1,-3.3,hsa04666,Fc gamma R-mediated phagocytosis,M1,1,0
1,-8.6,GDP01758,Coronary Heart Disease,M1,1,0
1,-2,GO:2001244,positive regulation of intrinsic apoptotic signaling pathway,M1,1,0
1,-4,M197,PID HIV NEF PATHWAY,M1,1,0
1,-9,GO:0040013,negative regulation of locomotion,M1,1,0
1,-2.9,GO:0035640,exploration behavior,M1,1,0
1,-8,GDP05254,Obesity,M1,1,0
1,-7.7,GO:0006898,receptor-mediated endocytosis,M1,1,0
1,-2.8,GO:0036314,response to sterol,M1,1,0
1,-2.4,GO:0032091,negative regulation of protein binding,M1,1,0
1,-2.6,hsa04270,Vascular smooth muscle contraction,M1,1,0
1,-2.6,GO:0060251,regulation of glial cell proliferation,M1,1,0
1,-3.8,M156,PID ECADHERIN NASCENT AJ PATHWAY,M1,1,0
1,-3.9,GO:0001570,vasculogenesis,M1,1,0
1,-2.2,WP3286,Copper homeostasis,M1,1,0
1,-6,GO:0009411,response to UV,M1,1,0
1,-3,GO:0070301,cellular response to hydrogen peroxide,M1,1,0
1,-3.7,GO:0048598,embryonic morphogenesis,M1,1,0
1,-6.1,GO:0001894,tissue homeostasis,M1,1,0
1,-2.2,GDP01661,Congenital heart defects,M1,1,0
1,-4.8,GO:0032970,regulation of actin filament-based process,M1,1,0
1,-4.1,GDP06824,Strabismus,M1,1,0
1,-3.3,GO:1901605,alpha-amino acid metabolic process,M1,1,0
1,-2.8,WP4496,Signal transduction through IL1R,M1,1,0
1,-4.3,GO:0044089,positive regulation of cellular component biogenesis,M1,1,0
1,-8.9,GO:0198738,cell-cell signaling by wnt,M1,1,0
1,-3.5,GO:0032092,positive regulation of protein binding,M1,1,0
1,-3.3,WP2406,Cardiac progenitor differentiation,M1,1,0
1,-8.4,hsa04936,Alcoholic liver disease,M1,1,0
1,-4.9,GO:0034766,negative regulation of monoatomic ion transmembrane transport,M1,1,0
1,-4.3,hsa04923,Regulation of lipolysis in adipocytes,M1,1,0
1,-3.9,GO:0098926,postsynaptic signal transduction,M1,1,0
1,-5.7,GO:0003014,renal system process,M1,1,0
1,-2.1,WP5180,DYRK1A,M1,1,0
1,-2.7,GO:0051495,positive regulation of cytoskeleton organization,M1,1,0
1,-4.5,R-HSA-1660499,Synthesis of PIPs at the plasma membrane,M1,1,0
1,-2.2,GO:0051276,chromosome organization,M1,1,0
1,-4.7,GO:0045921,positive regulation of exocytosis,M1,1,0
1,-4.5,GO:0019058,viral life cycle,M1,1,0
1,-2.4,GO:0043268,positive regulation of potassium ion transport,M1,1,0
1,-2.2,GO:1901988,negative regulation of cell cycle phase transition,M1,1,0
1,-14,GO:0006812,monoatomic cation transport,M1,1,0
1,-3.3,GO:1904645,response to amyloid-beta,M1,1,0
1,-3.6,GO:0035864,response to potassium ion,M1,1,0
1,-2.7,GO:0046326,positive regulation of glucose import,M1,1,0
1,-2.4,GO:0050821,protein stabilization,M1,1,0
1,-5.1,hsa04625,C-type lectin receptor signaling pathway,M1,1,0
1,-3.4,M184,PID ECADHERIN KERATINOCYTE PATHWAY,M1,1,0
1,-7.3,hsa05163,Human cytomegalovirus infection,M1,1,0
1,-3.1,GO:0036465,synaptic vesicle recycling,M1,1,0
1,-3.5,GO:0048565,digestive tract development,M1,1,0
1,-6.2,GO:0030111,regulation of Wnt signaling pathway,M1,1,0
1,-9.6,GO:0098660,inorganic ion transmembrane transport,M1,1,0
1,-3.5,GO:0050870,positive regulation of T cell activation,M1,1,0
1,-3.5,R-HSA-983712,Ion channel transport,M1,1,0
1,-2.8,GO:0043200,response to amino acid,M1,1,0
1,-7.4,WP4216,Chromosomal and microsatellite instability in colorectal cancer,M1,1,0
1,-2.5,GO:0032881,regulation of polysaccharide metabolic process,M1,1,0
1,-4.9,WP4396,Nonalcoholic fatty liver disease,M1,1,0
1,-2,GO:0001947,heart looping,M1,1,0
1,-2.9,GO:0001763,morphogenesis of a branching structure,M1,1,0
1,-3.1,GO:0072009,nephron epithelium development,M1,1,0
1,-2.9,GO:0034767,positive regulation of monoatomic ion transmembrane transport,M1,1,0
1,-3.2,GO:0032094,response to food,M1,1,0
1,-3.7,GO:0044770,cell cycle phase transition,M1,1,0
1,-9.4,GO:0150104,transport across blood-brain barrier,M1,1,0
1,-2.2,GO:0035265,organ growth,M1,1,0
1,-2.9,WP5122,Prostaglandin and leukotriene metabolism in senescence,M1,1,0
1,-2.5,GO:0030901,midbrain development,M1,1,0
1,-3.8,GO:0006525,arginine metabolic process,M1,1,0
1,-6.9,R-HSA-2029480,Fcgamma receptor (FCGR) dependent phagocytosis,M1,1,0
1,-2.7,WP4331,Neovascularisation processes,M1,1,0
1,-6.2,GO:0001525,angiogenesis,M1,1,0
1,-2.6,GO:1903322,positive regulation of protein modification by small protein conjugation or removal,M1,1,0
1,-2.2,GDP05059,Nervous System Disorder,M1,1,0
1,-5.8,GO:0045834,positive regulation of lipid metabolic process,M1,1,0
1,-6,hsa04072,Phospholipase D signaling pathway,M1,1,0
1,-19,GO:0043549,regulation of kinase activity,M1,1,0
1,-3.3,GDP05495,Palmoplantar keratoderma,M1,1,0
1,-2.7,GO:0022600,digestive system process,M1,1,0
1,-4.1,GDP03318,Hyperinsulinism,M1,1,0
1,-4.2,hsa04550,Signaling pathways regulating pluripotency of stem cells,M1,1,0
1,-4.4,WP2795,Cardiac hypertrophic response,M1,1,0
1,-5.2,GO:0043116,negative regulation of vascular permeability,M1,1,0
1,-2.5,GO:0044282,small molecule catabolic process,M1,1,0
1,-2.5,GO:0016053,organic acid biosynthetic process,M1,1,0
1,-2.2,hsa05134,Legionellosis,M1,1,0
1,-4,GO:0002768,immune response-regulating cell surface receptor signaling pathway,M1,1,0
1,-7.2,R-HSA-194138,Signaling by VEGF,M1,1,0
1,-3.2,GO:0048168,regulation of neuronal synaptic plasticity,M1,1,0
1,-2.1,GO:0050853,B cell receptor signaling pathway,M1,1,0
1,-2.4,R-HSA-2682334,EPH-Ephrin signaling,M1,1,0
1,-4.5,M286,PID TGFBR PATHWAY,M1,1,0
1,-4.6,GDP06395,Salivary gland neoplasm,M1,1,0
1,-2.6,R-HSA-9664323,FCGR3A-mediated IL10 synthesis,M1,1,0
1,-3.2,GO:0045229,external encapsulating structure organization,M1,1,0
1,-3.3,GO:0061437,renal system vasculature development,M1,1,0
1,-4.5,GO:0035994,response to muscle stretch,M1,1,0
1,-6.9,M195,PID CMYB PATHWAY,M1,1,0
1,-5.3,WP4223,Ras signaling,M1,1,0
1,-4.7,GO:0002764,immune response-regulating signaling pathway,M1,1,0
1,-3.4,GO:0030520,intracellular estrogen receptor signaling pathway,M1,1,0
1,-2.2,R-HSA-9006927,Signaling by Non-Receptor Tyrosine Kinases,M1,1,0
1,-5.7,GDP02841,Glomerulosclerosis,M1,1,0
1,-2.6,GO:0009582,detection of abiotic stimulus,M1,1,0
1,-7.2,WP4673,Male infertility,M1,1,0
1,-3.9,WP481,Insulin signaling,M1,1,0
1,-3.8,GDP05407,Osteopenia,M1,1,0
1,-7.4,GO:0002694,regulation of leukocyte activation,M1,1,0
1,-2.1,GO:0071356,cellular response to tumor necrosis factor,M1,1,0
1,-3.7,GDP00486,Aortic Valve Insufficiency,M1,1,0
1,-3.4,GDP00614,Atrial Septal Defect,M1,1,0
1,-4.6,GO:0007548,sex differentiation,M1,1,0
1,-4.3,GO:0043502,regulation of muscle adaptation,M1,1,0
1,-5.1,hsa04062,Chemokine signaling pathway,M1,1,0
1,-2.6,GO:0050728,negative regulation of inflammatory response,M1,1,0
1,-4.7,WP1971,Integrated cancer pathway,M1,1,0
1,-3.6,GO:0048593,camera-type eye morphogenesis,M1,1,0
1,-2.7,R-HSA-6806834,Signaling by MET,M1,1,0
1,-2.2,WP4917,Proximal tubule transport,M1,1,0
1,-2.8,WP4481,Resistin as a regulator of inflammation,M1,1,0
1,-2.4,GDP07342,Vulval varices,M1,1,0
1,-2,GO:1903708,positive regulation of hemopoiesis,M1,1,0
1,-2.2,hsa03013,Nucleocytoplasmic transport,M1,1,0
1,-3.2,GO:0032368,regulation of lipid transport,M1,1,0
1,-4.1,GO:0043535,regulation of blood vessel endothelial cell migration,M1,1,0
1,-4.1,M177,PID EPHA FWDPATHWAY,M1,1,0
1,-2.7,GO:0006974,DNA damage response,M1,1,0
1,-3.4,GO:0060444,branching involved in mammary gland duct morphogenesis,M1,1,0
1,-3,WP45,G1 to S cell cycle control,M1,1,0
1,-3,GDP04147,Lipodystrophy,M1,1,0
1,-2,GO:0030239,myofibril assembly,M1,1,0
1,-4.6,GO:0097485,neuron projection guidance,M1,1,0
1,-2.1,GDP02278,Eczema,M1,1,0
1,-3.5,R-HSA-512988,"Interleukin-3, Interleukin-5 and GM-CSF signaling",M1,1,0
1,-6.6,GO:0038096,Fc-gamma receptor signaling pathway involved in phagocytosis,M1,1,0
1,-3.5,GO:0051640,organelle localization,M1,1,0
1,-4.7,GDP06207,Renal cyst,M1,1,0
1,-3.1,GO:1903076,regulation of protein localization to plasma membrane,M1,1,0
1,-2.3,GO:1905477,positive regulation of protein localization to membrane,M1,1,0
1,-2,GO:0051170,import into nucleus,M1,1,0
1,-2.3,GO:0090316,positive regulation of intracellular protein transport,M1,1,0
1,-5.3,M200,PID ERA GENOMIC PATHWAY,M1,1,0
1,-2.9,GO:0090101,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,M1,1,0
1,-2.4,GO:0032869,cellular response to insulin stimulus,M1,1,0
1,-3.6,M12,PID RHOA PATHWAY,M1,1,0
1,-2.9,GO:0032446,protein modification by small protein conjugation,M1,1,0
1,-6.3,GO:1904951,positive regulation of establishment of protein localization,M1,1,0
1,-4.4,GO:0035725,sodium ion transmembrane transport,M1,1,0
1,-2.4,GO:0031648,protein destabilization,M1,1,0
1,-6.9,WP4806,EGFR tyrosine kinase inhibitor resistance,M1,1,0
1,-4.2,GO:0010720,positive regulation of cell development,M1,1,0
1,-2.7,GO:0030323,respiratory tube development,M1,1,0
1,-10,hsa04933,AGE-RAGE signaling pathway in diabetic complications,M1,1,0
1,-3.2,GDP06447,Scleroderma,M1,1,0
1,-3.9,GO:0044409,entry into host,M1,1,0
1,-3.4,GDP02489,Exocrine pancreatic insufficiency,M1,1,0
1,-3.7,GO:0050999,regulation of nitric-oxide synthase activity,M1,1,0
1,-3.4,WP3657,Hematopoietic stem cell gene regulation by GABP alpha/beta complex,M1,1,0
1,-2.2,GO:2001242,regulation of intrinsic apoptotic signaling pathway,M1,1,0
1,-9.8,hsa04022,cGMP-PKG signaling pathway,M1,1,0
1,-2.7,M13,PID ERBB4 PATHWAY,M1,1,0
1,-12,GO:0071900,regulation of protein serine/threonine kinase activity,M1,1,0
1,-13,WP51,Regulation of actin cytoskeleton,M1,1,0
1,-2.4,R-HSA-8957322,Metabolism of steroids,M1,1,0
1,-3.4,R-HSA-9768919,NPAS4 regulates expression of target genes,M1,1,0
1,-3.1,GO:0046209,nitric oxide metabolic process,M1,1,0
1,-11,GO:0050708,regulation of protein secretion,M1,1,0
1,-3.6,GO:0034614,cellular response to reactive oxygen species,M1,1,0
1,-3.1,R-HSA-8856825,Cargo recognition for clathrin-mediated endocytosis,M1,1,0
1,-3.2,GO:0061351,neural precursor cell proliferation,M1,1,0
1,-3.4,GO:0043433,negative regulation of DNA-binding transcription factor activity,M1,1,0
1,-5.6,GO:0043552,positive regulation of phosphatidylinositol 3-kinase activity,M1,1,0
1,-5.4,GO:0007229,integrin-mediated signaling pathway,M1,1,0
1,-3,GO:0043523,regulation of neuron apoptotic process,M1,1,0
1,-5.8,GO:0009410,response to xenobiotic stimulus,M1,1,0
1,-3.4,GO:0007519,skeletal muscle tissue development,M1,1,0
1,-2.9,hsa05230,Central carbon metabolism in cancer,M1,1,0
1,-7.6,GO:0000902,cell morphogenesis,M1,1,0
1,-5.6,GO:0030879,mammary gland development,M1,1,0
1,-2.5,R-HSA-3858494,Beta-catenin independent WNT signaling,M1,1,0
1,-6.5,GO:0043122,regulation of I-kappaB kinase/NF-kappaB signaling,M1,1,0
1,-2.3,R-HSA-1474244,Extracellular matrix organization,M1,1,0
1,-5.4,GO:0090209,negative regulation of triglyceride metabolic process,M1,1,0
1,-2.2,GO:0021549,cerebellum development,M1,1,0
1,-2.4,GO:0098609,cell-cell adhesion,M1,1,0
1,-5.2,GO:0009743,response to carbohydrate,M1,1,0
1,-2.7,GO:0060323,head morphogenesis,M1,1,0
1,-2.2,R-HSA-168898,Toll-like Receptor Cascades,M1,1,0
1,-4.5,M162,PID RXR VDR PATHWAY,M1,1,0
1,-3,GO:0006941,striated muscle contraction,M1,1,0
1,-3.4,GDP07077,Thyroid Gland Follicular Adenoma,M1,1,0
1,-6.6,R-HSA-170834,Signaling by TGF-beta Receptor Complex,M1,1,0
1,-5.1,hsa04924,Renin secretion,M1,1,0
1,-3.6,GO:1990573,potassium ion import across plasma membrane,M1,1,0
1,-2.9,GO:0006886,intracellular protein transport,M1,1,0
1,-5,R-HSA-6785807,Interleukin-4 and Interleukin-13 signaling,M1,1,0
1,-2.1,GO:0002521,leukocyte differentiation,M1,1,0
1,-4.2,GO:0019755,one-carbon compound transport,M1,1,0
1,-3.6,GDP02352,Enlarged polycystic ovaries,M1,1,0
1,-5.1,WP2380,Brain-derived neurotrophic factor (BDNF) signaling pathway,M1,1,0
1,-16,GO:0010035,response to inorganic substance,M1,1,0
1,-16,GDP04906,Myocardial Infarction,M1,1,0
1,-2.2,GO:0010518,positive regulation of phospholipase activity,M1,1,0
1,-2.1,GDP03294,Hypercalcemia,M1,1,0
1,-7.2,R-HSA-2219530,Constitutive Signaling by Aberrant PI3K in Cancer,M1,1,0
1,-3.7,hsa01521,EGFR tyrosine kinase inhibitor resistance,M1,1,0
1,-12,GO:0001934,positive regulation of protein phosphorylation,M1,1,0
1,-3.9,WP5055,Burn wound healing,M1,1,0
1,-10,R-HSA-9006925,Intracellular signaling by second messengers,M1,1,0
1,-4,hsa04922,Glucagon signaling pathway,M1,1,0
1,-8,GDP06834,Stroke,M1,1,0
1,-4,GO:0072657,protein localization to membrane,M1,1,0
1,-7.7,GO:1904062,regulation of monoatomic cation transmembrane transport,M1,1,0
1,-2.8,GO:0000096,sulfur amino acid metabolic process,M1,1,0
1,-7.8,GO:0010811,positive regulation of cell-substrate adhesion,M1,1,0
1,-2.3,GO:0061178,regulation of insulin secretion involved in cellular response to glucose stimulus,M1,1,0
1,-2.9,GDP04338,Malabsorption Syndrome,M1,1,0
1,-3.2,GO:0051588,regulation of neurotransmitter transport,M1,1,0
1,-2.3,GO:0010631,epithelial cell migration,M1,1,0
1,-5.8,WP2870,Extracellular vesicle-mediated signaling in recipient cells,M1,1,0
1,-2.1,GO:0051480,regulation of cytosolic calcium ion concentration,M1,1,0
1,-4.1,M34,PID TCR PATHWAY,M1,1,0
1,-2.9,GO:0019221,cytokine-mediated signaling pathway,M1,1,0
1,-3,GO:0021782,glial cell development,M1,1,0
1,-6.3,GO:0045216,cell-cell junction organization,M1,1,0
1,-3.3,GO:0006954,inflammatory response,M1,1,0
1,-2.2,GO:0003205,cardiac chamber development,M1,1,0
1,-3.6,GO:0032374,regulation of cholesterol transport,M1,1,0
1,-2.1,GO:0140115,export across plasma membrane,M1,1,0
1,-9.9,hsa04068,FoxO signaling pathway,M1,1,0
1,-3.7,WP3935,Leptin-insulin signaling overlap,M1,1,0
1,-4.9,GO:0045927,positive regulation of growth,M1,1,0
1,-4.6,GO:0009267,cellular response to starvation,M1,1,0
1,-10,GO:0009896,positive regulation of catabolic process,M1,1,0
1,-4.1,GO:0035865,cellular response to potassium ion,M1,1,0
1,-4.2,GO:0010718,positive regulation of epithelial to mesenchymal transition,M1,1,0
1,-2.8,WP4874,CAMKK2 pathway,M1,1,0
1,-4.4,GO:1901990,regulation of mitotic cell cycle phase transition,M1,1,0
1,-4.8,GO:1902806,regulation of cell cycle G1/S phase transition,M1,1,0
1,-2.9,GO:0095500,acetylcholine receptor signaling pathway,M1,1,0
1,-3.7,GDP05393,Osteochondrodysplasia,M1,1,0
1,-7.9,R-HSA-109582,Hemostasis,M1,1,0
1,-2.5,R-HSA-1433557,Signaling by SCF-KIT,M1,1,0
1,-3,GO:0090130,tissue migration,M1,1,0
1,-4.9,GO:0010717,regulation of epithelial to mesenchymal transition,M1,1,0
1,-6.6,GO:0031668,cellular response to extracellular stimulus,M1,1,0
1,-2.6,GO:0033555,multicellular organismal response to stress,M1,1,0
1,-2,M28,PID IL4 2PATHWAY,M1,1,0
1,-3,GO:0050679,positive regulation of epithelial cell proliferation,M1,1,0
1,-3.5,R-HSA-69236,G1 Phase,M1,1,0
1,-3.9,R-HSA-8864260,Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors,M1,1,0
1,-2.4,M128,PID TNF PATHWAY,M1,1,0
1,-7.5,hsa05206,MicroRNAs in cancer,M1,1,0
1,-13,GDP00611,Atrial Fibrillation,M1,1,0
1,-4.3,WP4879,Overlap between signal transduction pathways contributing to LMNA laminopathies,M1,1,0
1,-2.6,GDP06246,Retinal Detachment,M1,1,0
1,-4.1,R-HSA-203615,eNOS activation,M1,1,0
1,-2.1,GO:0033059,cellular pigmentation,M1,1,0
1,-3.4,WP4971,Phosphoinositides metabolism,M1,1,0
1,-3,GO:0042886,amide transport,M1,1,0
1,-2.4,GO:0002861,regulation of inflammatory response to antigenic stimulus,M1,1,0
1,-2.1,GDP04205,Lung Diseases,M1,1,0
1,-3.4,GO:0002089,lens morphogenesis in camera-type eye,M1,1,0
1,-3,WP43,Oxidation by cytochrome P450,M1,1,0
1,-3.8,GO:0031295,T cell costimulation,M1,1,0
1,-6.6,GO:0002433,immune response-regulating cell surface receptor signaling pathway involved in phagocytosis,M1,1,0
1,-13,R-HSA-5683057,MAPK family signaling cascades,M1,1,0
1,-5.7,GO:0060562,epithelial tube morphogenesis,M1,1,0
1,-2.1,GDP07083,Thyroid Neoplasm,M1,1,0
1,-4.9,GO:0097205,renal filtration,M1,1,0
1,-9.3,hsa05166,Human T-cell leukemia virus 1 infection,M1,1,0
1,-3.4,GDP03739,Intestinal Neoplasms,M1,1,0
1,-6.3,GO:0032409,regulation of transporter activity,M1,1,0
1,-2,GO:0032787,monocarboxylic acid metabolic process,M1,1,0
1,-4.9,GO:0030890,positive regulation of B cell proliferation,M1,1,0
1,-2.5,GO:0044058,regulation of digestive system process,M1,1,0
1,-3.9,GO:1901888,regulation of cell junction assembly,M1,1,0
1,-4.5,hsa04961,Endocrine and other factor-regulated calcium reabsorption,M1,1,0
1,-2.7,GDP03742,Intestinal Polyposis,M1,1,0
1,-3.2,R-HSA-5607764,CLEC7A (Dectin-1) signaling,M1,1,0
1,-3.4,GO:0010224,response to UV-B,M1,1,0
1,-7.9,WP4155,Endometrial cancer,M1,1,0
1,-4,GDP02053,Diabetic Asymmetric Polyneuropathy,M1,1,0
1,-8.5,R-HSA-9009391,Extra-nuclear estrogen signaling,M1,1,0
1,-3.1,WP304,Kit receptor signaling pathway,M1,1,0
1,-3.4,WP3599,Transcription factor regulation in adipogenesis,M1,1,0
1,-6,GDP03317,Hyperinsulinemic hypoglycemia,M1,1,0
1,-3.9,GO:0090263,positive regulation of canonical Wnt signaling pathway,M1,1,0
1,-2.8,GO:0042310,vasoconstriction,M1,1,0
1,-3,GO:0014013,regulation of gliogenesis,M1,1,0
1,-2.3,WP1533,Vitamin B12 metabolism,M1,1,0
1,-4,hsa04659,Th17 cell differentiation,M1,1,0
1,-6.1,GO:0031344,regulation of cell projection organization,M1,1,0
1,-2.6,GO:0035272,exocrine system development,M1,1,0
1,-3.5,R-HSA-9013149,RAC1 GTPase cycle,M1,1,0
1,-2.1,GO:0043254,regulation of protein-containing complex assembly,M1,1,0
1,-2.5,M238,PID THROMBIN PAR1 PATHWAY,M1,1,0
1,-4.8,R-HSA-9012999,RHO GTPase cycle,M1,1,0
1,-2.9,GO:0090092,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,M1,1,0
1,-2.1,GO:0032386,regulation of intracellular transport,M1,1,0
1,-2.2,GO:0051438,regulation of ubiquitin-protein transferase activity,M1,1,0
1,-3.8,GO:2000650,negative regulation of sodium ion transmembrane transporter activity,M1,1,0
1,-2.6,GO:0045321,leukocyte activation,M1,1,0
1,-2.1,R-HSA-168179,Toll Like Receptor TLR1:TLR2 Cascade,M1,1,0
1,-6.2,GO:0034599,cellular response to oxidative stress,M1,1,0
1,-5.4,GO:0031175,neuron projection development,M1,1,0
1,-7.2,GO:0050804,modulation of chemical synaptic transmission,M1,1,0
1,-3.4,M231,PID KIT PATHWAY,M1,1,0
1,-3.8,GO:0042307,positive regulation of protein import into nucleus,M1,1,0
1,-2.8,GO:0045669,positive regulation of osteoblast differentiation,M1,1,0
1,-3.6,GO:0098815,modulation of excitatory postsynaptic potential,M1,1,0
1,-14,GO:1901652,response to peptide,M1,1,0
1,-3.1,GO:0021915,neural tube development,M1,1,0
1,-4,GDP04752,Mood Disorder,M1,1,0
1,-4.6,GO:0043065,positive regulation of apoptotic process,M1,1,0
1,-8.3,GO:0035150,regulation of tube size,M1,1,0
1,-8.3,R-HSA-449147,Signaling by Interleukins,M1,1,0
1,-6.7,GO:0018212,peptidyl-tyrosine modification,M1,1,0
1,-4.2,GDP05537,Papillomatosis,M1,1,0
1,-3.7,GO:1901201,regulation of extracellular matrix assembly,M1,1,0
1,-2.4,GDP02939,Gynecomastia,M1,1,0
1,-2.9,R-HSA-187037,Signaling by NTRK1 (TRKA),M1,1,0
1,-3,R-HSA-211897,Cytochrome P450 - arranged by substrate type,M1,1,0
1,-7.4,M92,PID ANGIOPOIETIN RECEPTOR PATHWAY,M1,1,0
1,-3.5,R-HSA-9024446,NR1H2 and NR1H3-mediated signaling,M1,1,0
1,-2.2,GO:0001541,ovarian follicle development,M1,1,0
1,-2.6,R-HSA-9679506,SARS-CoV Infections,M1,1,0
1,-2.5,GO:2000241,regulation of reproductive process,M1,1,0
1,-3.8,GO:1903409,reactive oxygen species biosynthetic process,M1,1,0
1,-6.4,GO:0042391,regulation of membrane potential,M1,1,0
1,-11,GO:0009991,response to extracellular stimulus,M1,1,0
1,-4.3,GO:1903052,positive regulation of proteolysis involved in protein catabolic process,M1,1,0
1,-4.8,GO:2000300,regulation of synaptic vesicle exocytosis,M1,1,0
1,-4.9,hsa05169,Epstein-Barr virus infection,M1,1,0
1,-2.7,GO:1905144,response to acetylcholine,M1,1,0
1,-3.5,GO:0010595,positive regulation of endothelial cell migration,M1,1,0
1,-3,GO:0033157,regulation of intracellular protein transport,M1,1,0
1,-5.6,GO:0031347,regulation of defense response,M1,1,0
1,-5.9,WP2583,T cell receptor and co-stimulatory signaling,M1,1,0
1,-2.2,GO:0071773,cellular response to BMP stimulus,M1,1,0
1,-2.4,GO:0003073,regulation of systemic arterial blood pressure,M1,1,0
1,-4.1,GDP05990,Proptosis,M1,1,0
1,-2.4,M87,PID LKB1 PATHWAY,M1,1,0
1,-10,GO:0048511,rhythmic process,M1,1,0
1,-3.8,GDP03941,Knee osteoarthritis,M1,1,0
1,-4,hsa04066,HIF-1 signaling pathway,M1,1,0
1,-5.1,GO:0031345,negative regulation of cell projection organization,M1,1,0
1,-5,GO:0150115,cell-substrate junction organization,M1,1,0
1,-4.1,WP536,Calcium regulation in cardiac cells,M1,1,0
1,-3.5,hsa04662,B cell receptor signaling pathway,M1,1,0
1,-3.1,WP4205,MET in type 1 papillary renal cell carcinoma,M1,1,0
1,-3,R-HSA-9615017,"FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes",M1,1,0
1,-2.4,GDP02761,Gastroesophageal Reflux Disease,M1,1,0
1,-2.1,GDP03031,Hemiplegia/hemiparesis,M1,1,0
1,-10,R-HSA-1257604,PIP3 activates AKT signaling,M1,1,0
1,-2.1,GDP01100,Cataract,M1,1,0
1,-2.4,GDP04027,Left Ventricular Hypertrophy,M1,1,0
1,-2.7,R-HSA-9687139,Aberrant regulation of mitotic cell cycle due to RB1 defects,M1,1,0
1,-2.6,GO:0007276,gamete generation,M1,1,0
1,-4.1,GDP06072,Pulmonary Fibrosis,M1,1,0
1,-3,GDP03342,Hyperparathyroidism,M1,1,0
1,-3.3,GO:0072132,mesenchyme morphogenesis,M1,1,0
1,-5.8,GO:0000904,cell morphogenesis involved in differentiation,M1,1,0
1,-4.3,GO:0030048,actin filament-based movement,M1,1,0
1,-2.8,hsa05152,Tuberculosis,M1,1,0
1,-3.5,GO:0023058,adaptation of signaling pathway,M1,1,0
1,-6.3,M145,PID P53 DOWNSTREAM PATHWAY,M1,1,0
1,-4.2,GO:0009615,response to virus,M1,1,0
1,-3.3,hsa05414,Dilated cardiomyopathy,M1,1,0
1,-3.5,R-HSA-418346,Platelet homeostasis,M1,1,0
1,-6.3,GO:0033135,regulation of peptidyl-serine phosphorylation,M1,1,0
1,-2.2,GO:0016925,protein sumoylation,M1,1,0
1,-4.1,WP1544,MicroRNAs in cardiomyocyte hypertrophy,M1,1,0
1,-3.5,GO:0015711,organic anion transport,M1,1,0
1,-4.1,GO:0048880,sensory system development,M1,1,0
1,-5,GO:0072001,renal system development,M1,1,0
1,-2.3,GDP00216,Acute Kidney Insufficiency,M1,1,0
1,-7.9,GO:2000146,negative regulation of cell motility,M1,1,0
1,-3.8,GDP01813,Craniosynostosis,M1,1,0
1,-3.2,GO:0060541,respiratory system development,M1,1,0
1,-2.1,GO:0060395,SMAD protein signal transduction,M1,1,0
1,-4.6,GO:0031397,negative regulation of protein ubiquitination,M1,1,0
1,-16,WP3888,VEGFA-VEGFR2 signaling,M1,1,0
1,-2.3,GO:0050863,regulation of T cell activation,M1,1,0
1,-3.1,GO:0070374,positive regulation of ERK1 and ERK2 cascade,M1,1,0
1,-2.7,M48,PID MET PATHWAY,M1,1,0
1,-3.7,WP4541,Hippo-Merlin signaling dysregulation,M1,1,0
1,-8.1,WP428,Wnt signaling,M1,1,0
1,-20,R-HSA-5663202,Diseases of signal transduction by growth factor receptors and second messengers,M1,1,0
1,-5.1,GO:0045667,regulation of osteoblast differentiation,M1,1,0
1,-9.8,GO:0002696,positive regulation of leukocyte activation,M1,1,0
1,-5.8,WP4787,Osteoblast differentiation and related diseases,M1,1,0
1,-3.5,GO:0016125,sterol metabolic process,M1,1,0
1,-2.4,GO:0060041,retina development in camera-type eye,M1,1,0
1,-3.4,GO:0035809,regulation of urine volume,M1,1,0
1,-5.8,R-HSA-5218920,VEGFR2 mediated vascular permeability,M1,1,0
1,-2.3,GO:1903202,negative regulation of oxidative stress-induced cell death,M1,1,0
1,-4.6,GO:0051960,regulation of nervous system development,M1,1,0
1,-2.2,GDP04495,Melanocytic nevus,M1,1,0
1,-2.7,GO:0007492,endoderm development,M1,1,0
1,-4.1,GO:0007292,female gamete generation,M1,1,0
1,-4.4,GO:0045766,positive regulation of angiogenesis,M1,1,0
1,-3,GO:0050673,epithelial cell proliferation,M1,1,0
1,-3,GO:0042177,negative regulation of protein catabolic process,M1,1,0
1,-2.6,hsa04012,ErbB signaling pathway,M1,1,0
1,-4.2,GO:1900024,regulation of substrate adhesion-dependent cell spreading,M1,1,0
1,-6.4,WP1403,AMP-activated protein kinase signaling,M1,1,0
1,-3.2,GDP04933,Myopathy,M1,1,0
1,-2.5,GDP07382,Wolff-Parkinson-White Syndrome,M1,1,0
1,-2.4,R-HSA-6802955,Paradoxical activation of RAF signaling by kinase inactive BRAF,M1,1,0
1,-2.7,GO:0043401,steroid hormone mediated signaling pathway,M1,1,0
1,-6,GO:0032103,positive regulation of response to external stimulus,M1,1,0
1,-4.9,GO:0003007,heart morphogenesis,M1,1,0
1,-4.8,GDP04555,Metabolic Syndrome,M1,1,0
1,-13,GO:0034330,cell junction organization,M1,1,0
1,-4,R-HSA-425393,Transport of inorganic cations/anions and amino acids/oligopeptides,M1,1,0
1,-4.7,GO:1903828,negative regulation of protein localization,M1,1,0
1,-2.3,GO:0006110,regulation of glycolytic process,M1,1,0
1,-2.4,GO:1902882,regulation of response to oxidative stress,M1,1,0
1,-2.6,R-HSA-8875878,MET promotes cell motility,M1,1,0
1,-4.4,GDP02471,Esophagus Neoplasm,M1,1,0
1,-2.4,GO:0051492,regulation of stress fiber assembly,M1,1,0
1,-3,GO:0060603,mammary gland duct morphogenesis,M1,1,0
1,-2.4,GO:0050770,regulation of axonogenesis,M1,1,0
1,-3.7,GO:1902905,positive regulation of supramolecular fiber organization,M1,1,0
1,-3.3,GO:0036294,cellular response to decreased oxygen levels,M1,1,0
1,-7.6,GO:0045926,negative regulation of growth,M1,1,0
1,-3.9,GO:0001775,cell activation,M1,1,0
1,-3.4,GO:2001056,positive regulation of cysteine-type endopeptidase activity,M1,1,0
1,-5.6,GO:0098739,import across plasma membrane,M1,1,0
1,-5.1,R-HSA-388841,Costimulation by the CD28 family,M1,1,0
1,-2,GO:0032655,regulation of interleukin-12 production,M1,1,0
1,-2.4,GO:0046488,phosphatidylinositol metabolic process,M1,1,0
1,-2.7,GO:0050730,regulation of peptidyl-tyrosine phosphorylation,M1,1,0
1,-11,GO:0071559,response to transforming growth factor beta,M1,1,0
1,-8.9,M167,PID AP1 PATHWAY,M1,1,0
1,-2.8,GDP02680,Frontal bossing,M1,1,0
1,-4.3,hsa04915,Estrogen signaling pathway,M1,1,0
1,-3.1,GO:1903053,regulation of extracellular matrix organization,M1,1,0
1,-4,hsa04110,Cell cycle,M1,1,0
1,-2.2,GO:0071772,response to BMP,M1,1,0
1,-3.6,WP4301,Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells,M1,1,0
1,-5.3,WP4698,Vitamin D-sensitive calcium signaling in depression,M1,1,0
1,-3.4,GO:0030855,epithelial cell differentiation,M1,1,0
1,-7.5,GO:0032989,cellular component morphogenesis,M1,1,0
1,-12,GO:0031667,response to nutrient levels,M1,1,0
1,-4.2,M108,PID NETRIN PATHWAY,M1,1,0
1,-6.9,WP4298,Acute viral myocarditis,M1,1,0
1,-3,GDP05448,Ovarian neoplasm,M1,1,0
1,-5.2,GO:0045765,regulation of angiogenesis,M1,1,0
1,-3,GDP05991,"Prostate Cancer, Hereditary",M1,1,0
1,-4.2,GO:0030177,positive regulation of Wnt signaling pathway,M1,1,0
1,-2.9,WP4685,Melanoma,M1,1,0
1,-7.2,GO:0022602,ovulation cycle process,M1,1,0
1,-3.9,GO:0071453,cellular response to oxygen levels,M1,1,0
1,-2.2,GDP04176,Liver neoplasms,M1,1,0
1,-2.6,GO:0098656,monoatomic anion transmembrane transport,M1,1,0
1,-4.8,GO:0051897,positive regulation of protein kinase B signaling,M1,1,0
1,-9,GO:0098655,monoatomic cation transmembrane transport,M1,1,0
1,-3.1,GO:0071711,basement membrane organization,M1,1,0
1,-2.7,GO:0010952,positive regulation of peptidase activity,M1,1,0
1,-3.8,GO:0003012,muscle system process,M1,1,0
1,-2.3,hsa04979,Cholesterol metabolism,M1,1,0
1,-2.4,WP231,TNF-alpha signaling pathway,M1,1,0
1,-4,M105,PID TELOMERASE PATHWAY,M1,1,0
1,-6,R-HSA-354192,Integrin signaling,M1,1,0
1,-2,GO:0071384,cellular response to corticosteroid stimulus,M1,1,0
1,-2.2,hsa04064,NF-kappa B signaling pathway,M1,1,0
1,-2.9,GO:0006937,regulation of muscle contraction,M1,1,0
1,-4.4,GO:1904018,positive regulation of vasculature development,M1,1,0
1,-5.2,GO:2000045,regulation of G1/S transition of mitotic cell cycle,M1,1,0
1,-7.1,R-HSA-8941855,RUNX3 regulates CDKN1A transcription,M1,1,0
1,-17,GDP03364,Hypertension,M1,1,0
1,-5.4,GDP03310,Hyperglycemia,M1,1,0
1,-4.1,GO:0002218,activation of innate immune response,M1,1,0
1,-6.7,GDP02751,Gastric Cancer,M1,1,0
1,-6,M141,PID PI3KCI PATHWAY,M1,1,0
1,-3.5,R-HSA-112399,IRS-mediated signalling,M1,1,0
1,-6.5,WP4482,Vitamin D in inflammatory diseases,M1,1,0
1,-5.6,GO:0051924,regulation of calcium ion transport,M1,1,0
1,-3.8,M214,PID ERBB1 INTERNALIZATION PATHWAY,M1,1,0
1,-9,GDP04416,Marfan Syndrome,M1,1,0
1,-2.9,GO:0021953,central nervous system neuron differentiation,M1,1,0
1,-2.2,R-HSA-168164,Toll Like Receptor 3 (TLR3) Cascade,M1,1,0
1,-4.8,GO:0030097,hemopoiesis,M1,1,0
1,-2.7,GO:0007264,small GTPase mediated signal transduction,M1,1,0
1,-8.4,GO:0043086,negative regulation of catalytic activity,M1,1,0
1,-3.2,GO:0061180,mammary gland epithelium development,M1,1,0
1,-5.9,hsa04921,Oxytocin signaling pathway,M1,1,0
1,-2.5,GO:0051591,response to cAMP,M1,1,0
1,-3.7,GO:0032355,response to estradiol,M1,1,0
1,-4,GO:0014904,myotube cell development,M1,1,0
1,-7.6,R-HSA-4420097,VEGFA-VEGFR2 Pathway,M1,1,0
1,-2.2,GO:0019935,cyclic-nucleotide-mediated signaling,M1,1,0
1,-3.4,GO:0008277,regulation of G protein-coupled receptor signaling pathway,M1,1,0
1,-4.5,R-HSA-2173788,Downregulation of TGF-beta receptor signaling,M1,1,0
1,-2.4,GDP03576,Ileocolitis,M1,1,0
1,-3.7,GO:0071732,cellular response to nitric oxide,M1,1,0
1,-3.6,GO:1900026,positive regulation of substrate adhesion-dependent cell spreading,M1,1,0
1,-3.7,GO:0045429,positive regulation of nitric oxide biosynthetic process,M1,1,0
1,-2.2,GO:0009948,anterior/posterior axis specification,M1,1,0
1,-2.1,R-HSA-5696398,Nucleotide Excision Repair,M1,1,0
1,-2,GO:1904036,negative regulation of epithelial cell apoptotic process,M1,1,0
1,-3.6,GO:0050803,regulation of synapse structure or activity,M1,1,0
1,-3.8,R-HSA-9013106,RHOC GTPase cycle,M1,1,0
1,-5.4,GO:0008406,gonad development,M1,1,0
1,-2.1,GO:0050731,positive regulation of peptidyl-tyrosine phosphorylation,M1,1,0
1,-8.3,GO:0042326,negative regulation of phosphorylation,M1,1,0
1,-12,GDP00225,Adenocarcinoma,M1,1,0
1,-4,GDP02059,Diabetic Neuralgia,M1,1,0
1,-14,GO:0070848,response to growth factor,M1,1,0
1,-2.2,GO:0010559,regulation of glycoprotein biosynthetic process,M1,1,0
1,-2.2,GO:0043525,positive regulation of neuron apoptotic process,M1,1,0
1,-3.9,GDP00156,Acanthosis Nigricans,M1,1,0
1,-2.5,R-HSA-8980692,RHOA GTPase cycle,M1,1,0
1,-5,GO:0055064,chloride ion homeostasis,M1,1,0
1,-3.1,GO:0046486,glycerolipid metabolic process,M1,1,0
1,-3.7,GO:0050872,white fat cell differentiation,M1,1,0
1,-4.8,GO:0090400,stress-induced premature senescence,M1,1,0
1,-3,GO:0070293,renal absorption,M1,1,0
1,-4.2,GO:0045089,positive regulation of innate immune response,M1,1,0
1,-3.5,GO:1902170,cellular response to reactive nitrogen species,M1,1,0
1,-12,hsa05200,Pathways in cancer,M1,1,0
1,-8.3,GDP01384,Colonic Neoplasms,M1,1,0
1,-8.9,GO:0048638,regulation of developmental growth,M1,1,0
1,-11,GO:0007169,transmembrane receptor protein tyrosine kinase signaling pathway,M1,1,0
1,-2.3,R-HSA-5633007,Regulation of TP53 Activity,M1,1,0
1,-5.1,GO:0002757,immune response-activating signaling pathway,M1,1,0
1,-2.7,GDP07211,Ulcerative colitis,M1,1,0
1,-2.3,R-HSA-177929,Signaling by EGFR,M1,1,0
1,-5,WP4666,Hepatitis B infection,M1,1,0
1,-2.6,GO:0018209,peptidyl-serine modification,M1,1,0
1,-4.9,hsa04932,Non-alcoholic fatty liver disease,M1,1,0
1,-5.8,GO:0007178,transmembrane receptor protein serine/threonine kinase signaling pathway,M1,1,0
1,-2,R-HSA-1834949,Cytosolic sensors of pathogen-associated DNA,M1,1,0
1,-5.6,GDP01756,Coronary Arteriosclerosis,M1,1,0
1,-2.4,GO:0009791,post-embryonic development,M1,1,0
1,-7.4,R-HSA-1280215,Cytokine Signaling in Immune system,M1,1,0
1,-5.4,GO:0045599,negative regulation of fat cell differentiation,M1,1,0
1,-6.3,hsa05135,Yersinia infection,M1,1,0
1,-4.1,GO:0070542,response to fatty acid,M1,1,0
1,-11,M186,PID PDGFRB PATHWAY,M1,1,0
1,-5.7,GDP00600,Atherosclerosis,M1,1,0
1,-9.8,GDP01036,Carcinoma,M1,1,0
1,-3.7,GO:0050727,regulation of inflammatory response,M1,1,0
1,-8.1,GO:0046777,protein autophosphorylation,M1,1,0
1,-8.3,GO:0045862,positive regulation of proteolysis,M1,1,0
1,-3.9,hsa05223,Non-small cell lung cancer,M1,1,0
1,-2.2,GO:0030163,protein catabolic process,M1,1,0
1,-6.7,GO:0018108,peptidyl-tyrosine phosphorylation,M1,1,0
1,-4.2,GDP01066,Cardiomyopathy,M1,1,0
1,-5.2,WP3298,Melatonin metabolism and effects,M1,1,0
1,-12,WP4172,PI3K-Akt signaling pathway,M1,1,0
1,-8.3,GO:0006897,endocytosis,M1,1,0
1,-4,M295,SIG PIP3 SIGNALING IN CARDIAC MYOCTES,M1,1,0
1,-2,R-HSA-8878166,Transcriptional regulation by RUNX2,M1,1,0
1,-3.7,GO:0036293,response to decreased oxygen levels,M1,1,0
1,-4.9,GDP01311,Chronic Obstructive Pulmonary Disease,M1,1,0
1,-5.2,hsa05146,Amoebiasis,M1,1,0
1,-8.1,GO:0048514,blood vessel morphogenesis,M1,1,0
1,-2.9,WP707,DNA damage response,M1,1,0
1,-2.9,R-HSA-6802952,Signaling by BRAF and RAF1 fusions,M1,1,0
1,-5.5,GDP05187,Non-Alcoholic Fatty Liver Disease,M1,1,0
1,-2.7,GO:0035633,maintenance of blood-brain barrier,M1,1,0
1,-4.6,WP4539,Synaptic signaling pathways associated with autism spectrum disorder,M1,1,0
1,-3,GDP01390,Colorectal adenoma,M1,1,0
1,-3.9,GO:0007268,chemical synaptic transmission,M1,1,0
1,-2.3,GO:0010256,endomembrane system organization,M1,1,0
1,-2.6,GO:0051349,positive regulation of lyase activity,M1,1,0
1,-4.4,GO:0034764,positive regulation of transmembrane transport,M1,1,0
1,-2.2,GO:0042110,T cell activation,M1,1,0
1,-9.7,GO:0050865,regulation of cell activation,M1,1,0
1,-7.6,WP2586,Aryl hydrocarbon receptor pathway,M1,1,0
1,-2.1,GO:0090303,positive regulation of wound healing,M1,1,0
1,-5.7,WP5144,NRP1-triggered signaling pathways in pancreatic cancer,M1,1,0
1,-3.2,hsa05142,Chagas disease,M1,1,0
1,-6.6,GO:0070588,calcium ion transmembrane transport,M1,1,0
1,-8,hsa04213,Longevity regulating pathway - multiple species,M1,1,0
1,-9.9,GDP05589,Paroxysmal atrial fibrillation,M1,1,0
1,-3,GO:0001678,intracellular glucose homeostasis,M1,1,0
1,-3.5,GDP03870,Juvenile arthritis,M1,1,0
1,-7.5,GO:0010817,regulation of hormone levels,M1,1,0
1,-4.7,GDP06816,Stomach Neoplasms,M1,1,0
1,-2.7,M1315,SIG PIP3 SIGNALING IN B LYMPHOCYTES,M1,1,0
1,-6.6,hsa05170,Human immunodeficiency virus 1 infection,M1,1,0
1,-10,GO:0051098,regulation of binding,M1,1,0
1,-3.6,M16,PID INSULIN PATHWAY,M1,1,0
1,-2.4,GDP04776,Movement Disorders,M1,1,0
1,-2.5,GO:0046394,carboxylic acid biosynthetic process,M1,1,0
1,-5.1,GO:0042542,response to hydrogen peroxide,M1,1,0
1,-6.3,WP2332,Interleukin-11 signaling pathway,M1,1,0
1,-5.1,WP382,MAPK signaling pathway,M1,1,0
1,-2.2,GDP07363,West Syndrome,M1,1,0
1,-3.1,R-HSA-8986944,Transcriptional Regulation by MECP2,M1,1,0
1,-4.5,GO:0071478,cellular response to radiation,M1,1,0
1,-2.9,R-HSA-372790,Signaling by GPCR,M1,1,0
1,-3.4,GO:0051496,positive regulation of stress fiber assembly,M1,1,0
1,-9.7,R-HSA-6811558,"PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling",M1,1,0
1,-4.5,GO:0051099,positive regulation of binding,M1,1,0
1,-3.5,WP3287,Overview of nanoparticle effects,M1,1,0
1,-3.9,hsa04917,Prolactin signaling pathway,M1,1,0
1,-2.5,GO:2000134,negative regulation of G1/S transition of mitotic cell cycle,M1,1,0
1,-4.5,GO:0007409,axonogenesis,M1,1,0
1,-2.8,GO:0048147,negative regulation of fibroblast proliferation,M1,1,0
1,-5.7,GO:0019932,second-messenger-mediated signaling,M1,1,0
1,-3,GO:0030325,adrenal gland development,M1,1,0
1,-4.8,GO:0009611,response to wounding,M1,1,0
1,-2.2,GO:0030178,negative regulation of Wnt signaling pathway,M1,1,0
1,-5.3,GO:0030728,ovulation,M1,1,0
1,-4.1,GO:0006874,intracellular calcium ion homeostasis,M1,1,0
1,-2.7,R-HSA-162909,Host Interactions of HIV factors,M1,1,0
1,-4.5,GO:1903305,regulation of regulated secretory pathway,M1,1,0
1,-6.7,hsa04211,Longevity regulating pathway,M1,1,0
1,-3.1,GO:0048641,regulation of skeletal muscle tissue development,M1,1,0
1,-4.2,GO:0061136,regulation of proteasomal protein catabolic process,M1,1,0
1,-3,hsa05217,Basal cell carcinoma,M1,1,0
1,-3.2,GO:0019217,regulation of fatty acid metabolic process,M1,1,0
1,-2,hsa04929,GnRH secretion,M1,1,0
1,-3.6,GO:0006801,superoxide metabolic process,M1,1,0
1,-4.1,GO:0008610,lipid biosynthetic process,M1,1,0
1,-2.6,WP3941,Oxidative damage response,M1,1,0
1,-5.7,R-HSA-9824443,Parasitic Infection Pathways,M1,1,0
1,-2.4,GO:0030902,hindbrain development,M1,1,0
1,-3.3,GO:0070663,regulation of leukocyte proliferation,M1,1,0
1,-4.1,hsa04660,T cell receptor signaling pathway,M1,1,0
1,-3.6,GO:0090207,regulation of triglyceride metabolic process,M1,1,0
1,-5.8,GO:0051481,negative regulation of cytosolic calcium ion concentration,M1,1,0
1,-4.7,GO:0048639,positive regulation of developmental growth,M1,1,0
1,-7.8,GO:0071375,cellular response to peptide hormone stimulus,M1,1,0
1,-3,GDP06812,Still Disease,M1,1,0
1,-4,GO:0008286,insulin receptor signaling pathway,M1,1,0
1,-7.1,R-HSA-9824446,Viral Infection Pathways,M1,1,0
1,-2,GO:0016050,vesicle organization,M1,1,0
1,-6.7,hsa05161,Hepatitis B,M1,1,0
1,-5.6,GO:2001233,regulation of apoptotic signaling pathway,M1,1,0
1,-3.5,GO:0002064,epithelial cell development,M1,1,0
1,-3.9,GO:0044772,mitotic cell cycle phase transition,M1,1,0
1,-3.5,GO:0045744,negative regulation of G protein-coupled receptor signaling pathway,M1,1,0
1,-2,GDP05771,Physiologic Amenorrhea,M1,1,0
1,-2.9,GO:1903037,regulation of leukocyte cell-cell adhesion,M1,1,0
1,-5.3,WP23,B cell receptor signaling pathway,M1,1,0
1,-2.9,WP5130,Th17 cell differentiation pathway,M1,1,0
1,-2.1,GO:2001258,negative regulation of cation channel activity,M1,1,0
1,-5,R-HSA-5675221,Negative regulation of MAPK pathway,M1,1,0
1,-6.3,GO:0009314,response to radiation,M1,1,0
1,-3.5,GO:0099054,presynapse assembly,M1,1,0
1,-14,GO:0030335,positive regulation of cell migration,M1,1,0
1,-2.1,R-HSA-187577,SCF(Skp2)-mediated degradation of p27/p21,M1,1,0
1,-3,GO:0006641,triglyceride metabolic process,M1,1,0
1,-3,GO:1903055,positive regulation of extracellular matrix organization,M1,1,0
1,-4.1,GO:0022409,positive regulation of cell-cell adhesion,M1,1,0
1,-2,GO:0060079,excitatory postsynaptic potential,M1,1,0
1,-2.5,GDP01121,Celiac disease,M1,1,0
1,-2.8,GDP00773,Bicuspid aortic valve,M1,1,0
1,-3.4,R-HSA-389513,CTLA4 inhibitory signaling,M1,1,0
1,-2.3,GO:0002753,cytosolic pattern recognition receptor signaling pathway,M1,1,0
1,-5.2,R-HSA-9614085,FOXO-mediated transcription,M1,1,0
1,-2.9,GDP04226,Lymphoblastic Leukemia,M1,1,0
1,-3.5,GDP05840,"Polyarthritis, Rheumatoid Factor Positive",M1,1,0
1,-7.8,GO:0002028,regulation of sodium ion transport,M1,1,0
1,-2.2,GO:0032231,regulation of actin filament bundle assembly,M1,1,0
1,-4.4,GO:0001954,positive regulation of cell-matrix adhesion,M1,1,0
1,-2.6,GO:0032570,response to progesterone,M1,1,0
1,-5.3,GO:0045137,development of primary sexual characteristics,M1,1,0
1,-5.9,GO:0022604,regulation of cell morphogenesis,M1,1,0
1,-16,GDP01765,Coronary artery disease,M1,1,0
1,-11,GO:0007420,brain development,M1,1,0
1,-3.8,GO:0071482,cellular response to light stimulus,M1,1,0
1,-2.2,GO:0032784,regulation of DNA-templated transcription elongation,M1,1,0
1,-2.2,GO:0002221,pattern recognition receptor signaling pathway,M1,1,0
1,-6.3,hsa05418,Fluid shear stress and atherosclerosis,M1,1,0
1,-11,GO:0008285,negative regulation of cell population proliferation,M1,1,0
1,-2.9,GO:0015850,organic hydroxy compound transport,M1,1,0
1,-4.2,hsa04925,Aldosterone synthesis and secretion,M1,1,0
1,-4.1,M277,PID INTEGRIN A4B1 PATHWAY,M1,1,0
1,-5,WP3594,Circadian rhythm genes,M1,1,0
1,-2.5,GO:0071548,response to dexamethasone,M1,1,0
1,-4.2,GO:0010212,response to ionizing radiation,M1,1,0
1,-5.5,WP69,T-cell receptor signaling pathway,M1,1,0
1,-4.8,GO:0048017,inositol lipid-mediated signaling,M1,1,0
1,-6.7,GO:0030029,actin filament-based process,M1,1,0
1,-5.3,R-HSA-9617828,FOXO-mediated transcription of cell cycle genes,M1,1,0
1,-4.8,GO:0042594,response to starvation,M1,1,0
1,-8.3,GO:0045860,positive regulation of protein kinase activity,M1,1,0
1,-5.1,GO:0001822,kidney development,M1,1,0
1,-2.1,GO:0007265,Ras protein signal transduction,M1,1,0
1,-2.1,R-HSA-1236394,Signaling by ERBB4,M1,1,0
1,-6.6,GO:0051222,positive regulation of protein transport,M1,1,0
1,-2.4,GO:0006639,acylglycerol metabolic process,M1,1,0
1,-3.7,WP179,Cell cycle,M1,1,0
1,-3,GO:0006940,regulation of smooth muscle contraction,M1,1,0
1,-2.2,GDP04841,Multiple myeloma,M1,1,0
1,-7.3,R-HSA-8939211,ESR-mediated signaling,M1,1,0
1,-2.9,GO:0060325,face morphogenesis,M1,1,0
1,-3.6,GO:0032371,regulation of sterol transport,M1,1,0
1,-11,R-HSA-199418,Negative regulation of the PI3K/AKT network,M1,1,0
1,-2.2,R-HSA-8848021,Signaling by PTK6,M1,1,0
1,-4.4,GO:0034644,cellular response to UV,M1,1,0
1,-5,WP4321,Thermogenesis,M1,1,0
1,-2.6,GO:0031334,positive regulation of protein-containing complex assembly,M1,1,0
1,-6.8,GO:0048145,regulation of fibroblast proliferation,M1,1,0
1,-6,GO:0042311,vasodilation,M1,1,0
1,-4.8,M8626,SIG BCR SIGNALING PATHWAY,M1,1,0
1,-5.9,GO:0098771,inorganic ion homeostasis,M1,1,0
1,-2.7,GO:0019233,sensory perception of pain,M1,1,0
1,-2.5,WP4148,Splicing factor NOVA regulated synaptic proteins,M1,1,0
1,-2.1,WP61,Notch signaling pathway,M1,1,0
1,-5,GDP05431,Ovarian Carcinoma,M1,1,0
1,-3.4,WP35,G protein signaling pathways,M1,1,0
1,-2.9,GDP01349,Clonic Seizures,M1,1,0
1,-2.1,GO:1903018,regulation of glycoprotein metabolic process,M1,1,0
1,-3,GO:0048041,focal adhesion assembly,M1,1,0
1,-2.1,R-HSA-168188,Toll Like Receptor TLR6:TLR2 Cascade,M1,1,0
1,-2.2,GO:0003229,ventricular cardiac muscle tissue development,M1,1,0
1,-4.5,GO:0050864,regulation of B cell activation,M1,1,0
1,-6,hsa05167,Kaposi sarcoma-associated herpesvirus infection,M1,1,0
1,-4.2,GO:1904030,negative regulation of cyclin-dependent protein kinase activity,M1,1,0
1,-4.5,R-HSA-74751,Insulin receptor signalling cascade,M1,1,0
1,-4.5,hsa04380,Osteoclast differentiation,M1,1,0
1,-14,hsa04218,Cellular senescence,M1,1,0
1,-3.7,R-HSA-3928662,EPHB-mediated forward signaling,M1,1,0
1,-6.8,hsa05131,Shigellosis,M1,1,0
1,-6.2,GO:0032412,regulation of monoatomic ion transmembrane transporter activity,M1,1,0
1,-2.6,GDP05747,Phakomatosis pigmentovascularis,M1,1,0
1,-3.2,GO:0002931,response to ischemia,M1,1,0
1,-3.4,GDP02219,Dyskinetic Syndrome,M1,1,0
1,-2.7,GO:0031281,positive regulation of cyclase activity,M1,1,0
1,-2.7,GO:0018210,peptidyl-threonine modification,M1,1,0
1,-2.4,WP268,Notch signaling,M1,1,0
1,-2.1,R-HSA-195258,RHO GTPase Effectors,M1,1,0
1,-3.2,GO:0010508,positive regulation of autophagy,M1,1,0
1,-3.8,M82,PID RET PATHWAY,M1,1,0
1,-2.4,GO:1903307,positive regulation of regulated secretory pathway,M1,1,0
1,-4.1,GO:0032946,positive regulation of mononuclear cell proliferation,M1,1,0
1,-2.2,GO:0006826,iron ion transport,M1,1,0
1,-3.1,GDP06474,Seizure,M1,1,0
1,-9.5,GO:0055082,intracellular chemical homeostasis,M1,1,0
1,-2.2,GO:0061919,process utilizing autophagic mechanism,M1,1,0
1,-3.1,GDP06825,Strawberry Nevus Of Skin,M1,1,0
1,-3.1,GO:0031346,positive regulation of cell projection organization,M1,1,0
1,-7.8,WP2814,Mammary gland development pathway - Puberty (Stage 2 of 4),M1,1,0
1,-2.7,R-HSA-112316,Neuronal System,M1,1,0
1,-4.8,GO:0010975,regulation of neuron projection development,M1,1,0
1,-2.7,GO:0043281,regulation of cysteine-type endopeptidase activity involved in apoptotic process,M1,1,0
1,-4.8,GO:1901987,regulation of cell cycle phase transition,M1,1,0
1,-3.4,GO:0060047,heart contraction,M1,1,0
1,-2.4,GO:0072091,regulation of stem cell proliferation,M1,1,0
1,-7.4,WP5300,TROP2 regulatory signaling,M1,1,0
1,-2.6,GO:0044344,cellular response to fibroblast growth factor stimulus,M1,1,0
1,-5.2,R-HSA-76009,Platelet Aggregation (Plug Formation),M1,1,0
1,-5.8,GO:0046660,female sex differentiation,M1,1,0
1,-5.2,M101,PID HDAC CLASSI PATHWAY,M1,1,0
1,-2.6,GO:0001837,epithelial to mesenchymal transition,M1,1,0
1,-2.9,GDP01257,Cholangiocarcinoma,M1,1,0
1,-3.1,R-HSA-2029482,Regulation of actin dynamics for phagocytic cup formation,M1,1,0
1,-4.1,M266,PID NCADHERIN PATHWAY,M1,1,0
1,-2.1,GDP05911,Posteriorly Rotated Ear,M1,1,0
1,-2.7,R-HSA-5576891,Cardiac conduction,M1,1,0
1,-3.2,GO:0051153,regulation of striated muscle cell differentiation,M1,1,0
1,-2.3,GO:0050851,antigen receptor-mediated signaling pathway,M1,1,0
1,-3.1,GDP01972,Dementia,M1,1,0
1,-4.1,hsa04710,Circadian rhythm,M1,1,0
1,-2.5,GO:0001503,ossification,M1,1,0
1,-3.3,GO:0098719,sodium ion import across plasma membrane,M1,1,0
1,-4.4,WP3646,Hepatitis C and hepatocellular carcinoma,M1,1,0
1,-2.1,GO:0046578,regulation of Ras protein signal transduction,M1,1,0
1,-3.7,GDP03789,Ischemic Stroke,M1,1,0
1,-5.7,GO:0014068,positive regulation of phosphatidylinositol 3-kinase signaling,M1,1,0
1,-2.2,GO:2000648,positive regulation of stem cell proliferation,M1,1,0
1,-4.9,WP2118,Arrhythmogenic right ventricular cardiomyopathy,M1,1,0
1,-3.3,GO:0097242,amyloid-beta clearance,M1,1,0
1,-2,GDP04296,Macrocephaly,M1,1,0
1,-4.2,GO:0055123,digestive system development,M1,1,0
1,-6.8,GO:0051090,regulation of DNA-binding transcription factor activity,M1,1,0
1,-6,hsa05202,Transcriptional misregulation in cancer,M1,1,0
1,-13,GO:2000147,positive regulation of cell motility,M1,1,0
1,-2.6,GO:0045913,positive regulation of carbohydrate metabolic process,M1,1,0
1,-4.1,GO:0030888,regulation of B cell proliferation,M1,1,0
1,-5.2,GO:0040007,growth,M1,1,0
1,-3.4,R-HSA-389357,CD28 dependent PI3K/Akt signaling,M1,1,0
1,-2.5,GO:0001656,metanephros development,M1,1,0
1,-8.1,WP5322,CKAP4 signaling pathway map,M1,1,0
1,-2.6,GDP06192,Renal Insufficiency,M1,1,0
1,-3.8,GO:0055006,cardiac cell development,M1,1,0
1,-3.1,hsa04928,"Parathyroid hormone synthesis, secretion and action",M1,1,0
1,-3.9,R-HSA-354194,GRB2:SOS provides linkage to MAPK signaling for Integrins,M1,1,0
1,-5.7,GO:0006470,protein dephosphorylation,M1,1,0
1,-6.3,GO:1902893,regulation of miRNA transcription,M1,1,0
1,-2.2,GDP07299,Ventricular septal defect,M1,1,0
1,-3.2,GO:0030518,intracellular steroid hormone receptor signaling pathway,M1,1,0
1,-2.2,GO:1990748,cellular detoxification,M1,1,0
1,-2.3,hsa00330,Arginine and proline metabolism,M1,1,0
1,-6.4,GO:0050801,monoatomic ion homeostasis,M1,1,0
1,-9.1,GO:0033673,negative regulation of kinase activity,M1,1,0
1,-7.1,hsa05224,Breast cancer,M1,1,0
1,-2.1,R-HSA-6796648,TP53 Regulates Transcription of DNA Repair Genes,M1,1,0
1,-3.4,GO:0060218,hematopoietic stem cell differentiation,M1,1,0
1,-6.5,GO:0009416,response to light stimulus,M1,1,0
1,-8.8,GO:0043114,regulation of vascular permeability,M1,1,0
1,-4.7,WP2431,Spinal cord injury,M1,1,0
1,-4.5,GO:0048146,positive regulation of fibroblast proliferation,M1,1,0
1,-7.9,GDP04206,Lung Neoplasms,M1,1,0
1,-2.9,GO:0043270,positive regulation of monoatomic ion transport,M1,1,0
1,-3.2,GO:0021537,telencephalon development,M1,1,0
1,-10,WP4658,Small cell lung cancer,M1,1,0
1,-2.8,GO:0014902,myotube differentiation,M1,1,0
1,-3.4,WP673,ErbB signaling pathway,M1,1,0
1,-4.6,R-HSA-2173793,Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer,M1,1,0
1,-4.1,M254,PID MYC REPRESS PATHWAY,M1,1,0
1,-5.3,GO:0051893,regulation of focal adhesion assembly,M1,1,0
1,-6.8,M281,PID FAK PATHWAY,M1,1,0
1,-3.7,GO:0030278,regulation of ossification,M1,1,0
1,-15,WP366,TGF-beta signaling pathway,M1,1,0
1,-5.9,GO:0043393,regulation of protein binding,M1,1,0
1,-2.9,GO:0050670,regulation of lymphocyte proliferation,M1,1,0
1,-3.3,GO:0051129,negative regulation of cellular component organization,M1,1,0
1,-2.3,WP2267,Synaptic vesicle pathway,M1,1,0
1,-4.3,GO:1901203,positive regulation of extracellular matrix assembly,M1,1,0
1,-7.7,GO:0046883,regulation of hormone secretion,M1,1,0
1,-2,hsa03250,Viral life cycle - HIV-1,M1,1,0
1,-3.4,GO:0035924,cellular response to vascular endothelial growth factor stimulus,M1,1,0
1,-2.8,M40,PID E2F PATHWAY,M1,1,0
1,-4,hsa05160,Hepatitis C,M1,1,0
1,-5.1,GO:1901016,regulation of potassium ion transmembrane transporter activity,M1,1,0
1,-6.8,R-HSA-9664417,Leishmania phagocytosis,M1,1,0
1,-2.4,GO:0010907,positive regulation of glucose metabolic process,M1,1,0
1,-4.5,M113,PID NFAT 3PATHWAY,M1,1,0
1,-3.6,GO:1903047,mitotic cell cycle process,M1,1,0
1,-3.9,WP2447,Amyotrophic lateral sclerosis (ALS),M1,1,0
1,-2.1,WP5329,Cholesterol biosynthesis pathway in hepatocytes,M1,1,0
1,-3.9,WP4255,Non-small cell lung cancer,M1,1,0
1,-6.8,R-HSA-9664407,Parasite infection,M1,1,0
1,-7.9,GO:0060537,muscle tissue development,M1,1,0
1,-2.8,R-HSA-1296065,Inwardly rectifying K+ channels,M1,1,0
1,-2.2,GO:0006914,autophagy,M1,1,0
1,-3.4,GO:0060606,tube closure,M1,1,0
1,-2.5,WP49,IL-2 signaling pathway,M1,1,0
1,-5.3,R-HSA-3108232,SUMO E3 ligases SUMOylate target proteins,M1,1,0
1,-2.3,GO:0045776,negative regulation of blood pressure,M1,1,0
1,-2.1,GO:0002040,sprouting angiogenesis,M1,1,0
1,-4,WP3680,Physico-chemical features and toxicity-associated pathways,M1,1,0
1,-22,GDP01073,Cardiovascular Diseases,M1,1,0
1,-7.2,GO:0032990,cell part morphogenesis,M1,1,0
1,-5.3,GO:0090109,regulation of cell-substrate junction assembly,M1,1,0
1,-5.5,hsa05208,Chemical carcinogenesis - reactive oxygen species,M1,1,0
1,-6.1,hsa04930,Type II diabetes mellitus,M1,1,0
1,-2.5,R-HSA-166016,Toll Like Receptor 4 (TLR4) Cascade,M1,1,0
1,-3.4,GDP03425,Hypoglycemia,M1,1,0
1,-3.2,R-HSA-5578775,Ion homeostasis,M1,1,0
1,-16,R-HSA-9006934,Signaling by Receptor Tyrosine Kinases,M1,1,0
1,-2.2,R-HSA-163685,Integration of energy metabolism,M1,1,0
1,-8.8,WP4540,Hippo signaling regulation pathways,M1,1,0
1,-3.2,WP26,S1P receptor signal transduction,M1,1,0
1,-2.4,GDP00578,Astrocytoma,M1,1,0
1,-2.7,GO:0072175,epithelial tube formation,M1,1,0
1,-2.4,GO:0009636,response to toxic substance,M1,1,0
1,-2.2,GO:2001238,positive regulation of extrinsic apoptotic signaling pathway,M1,1,0
1,-6.9,GO:0022898,regulation of transmembrane transporter activity,M1,1,0
1,-4.2,GO:0097190,apoptotic signaling pathway,M1,1,0
1,-3,hsa04630,JAK-STAT signaling pathway,M1,1,0
1,-2.4,WP5115,Network map of SARS-CoV-2 signaling pathway,M1,1,0
1,-2.3,GO:0086001,cardiac muscle cell action potential,M1,1,0
1,-5.3,GO:1903321,negative regulation of protein modification by small protein conjugation or removal,M1,1,0
1,-10,GO:0050867,positive regulation of cell activation,M1,1,0
1,-2.3,GO:0038061,NIK/NF-kappaB signaling,M1,1,0
1,-2.1,R-HSA-166058,MyD88:MAL(TIRAP) cascade initiated on plasma membrane,M1,1,0
1,-9.1,GO:0010038,response to metal ion,M1,1,0
1,-2.9,GO:0010950,positive regulation of endopeptidase activity,M1,1,0
1,-3.3,M11,PID PRL SIGNALING EVENTS PATHWAY,M1,1,0
1,-5.3,GO:0071241,cellular response to inorganic substance,M1,1,0
1,-5.2,GO:0032373,positive regulation of sterol transport,M1,1,0
1,-2.2,GO:0050890,cognition,M1,1,0
1,-2.3,R-HSA-975871,MyD88 cascade initiated on plasma membrane,M1,1,0
1,-5.5,hsa04370,VEGF signaling pathway,M1,1,0
1,-5.6,GO:0043550,regulation of lipid kinase activity,M1,1,0
1,-3.9,GO:0033143,regulation of intracellular steroid hormone receptor signaling pathway,M1,1,0
1,-2.6,GO:0009581,detection of external stimulus,M1,1,0
1,-3.4,GO:0061008,hepaticobiliary system development,M1,1,0
1,-3.9,GO:0046676,negative regulation of insulin secretion,M1,1,0
1,-3.6,GO:0106027,neuron projection organization,M1,1,0
1,-13,GO:0007507,heart development,M1,1,0
1,-2,GO:0040014,regulation of multicellular organism growth,M1,1,0
1,-2.9,GO:0070252,actin-mediated cell contraction,M1,1,0
1,-4.5,GO:0010594,regulation of endothelial cell migration,M1,1,0
1,-5.6,WP5098,T-cell activation SARS-CoV-2,M1,1,0
1,-3.1,M187,PID TRKR PATHWAY,M1,1,0
1,-6.4,GO:0002431,Fc receptor mediated stimulatory signaling pathway,M1,1,0
1,-5.2,GO:0048589,developmental growth,M1,1,0
1,-2.8,M12705,SIG CD40PATHWAYMAP,M1,1,0
1,-8,GO:0010762,regulation of fibroblast migration,M1,1,0
1,-2.3,M136,PID FOXO PATHWAY,M1,1,0
1,-3,GO:1901798,positive regulation of signal transduction by p53 class mediator,M1,1,0
1,-3.4,GO:0043123,positive regulation of I-kappaB kinase/NF-kappaB signaling,M1,1,0
1,-14,GO:0045859,regulation of protein kinase activity,M1,1,0
1,-11,R-HSA-5673001,RAF/MAP kinase cascade,M1,1,0
1,-2.8,R-HSA-202403,TCR signaling,M1,1,0
1,-7.3,GO:0034765,regulation of monoatomic ion transmembrane transport,M1,1,0
1,-2.5,hsa05203,Viral carcinogenesis,M1,1,0
1,-4.2,GO:1902950,regulation of dendritic spine maintenance,M1,1,0
1,-5.1,GO:1904063,negative regulation of cation transmembrane transport,M1,1,0
1,-5.9,GO:0019216,regulation of lipid metabolic process,M1,1,0
1,-6.9,WP4262,Breast cancer pathway,M1,1,0
1,-2.2,GO:0002220,innate immune response activating cell surface receptor signaling pathway,M1,1,0
1,-6.1,GDP04658,Migraine,M1,1,0
1,-3.1,GO:0046324,regulation of glucose import,M1,1,0
1,-3.8,GO:0043536,positive regulation of blood vessel endothelial cell migration,M1,1,0
1,-3.3,M37,PID NFKAPPAB CANONICAL PATHWAY,M1,1,0
1,-2.2,WP2018,RANKL/RANK signaling pathway,M1,1,0
1,-2.6,GO:0016236,macroautophagy,M1,1,0
1,-3.4,GDP01373,Colitis,M1,1,0
1,-5.1,GO:0080135,regulation of cellular response to stress,M1,1,0
1,-3.2,M274,PID LYMPH ANGIOGENESIS PATHWAY,M1,1,0
1,-4.2,M58,PID AR PATHWAY,M1,1,0
1,-2.8,WP1982,Sterol regulatory element-binding proteins (SREBP) signaling,M1,1,0
1,-2.4,GO:0070527,platelet aggregation,M1,1,0
1,-2.5,GO:0008584,male gonad development,M1,1,0
1,-16,GO:0009725,response to hormone,M1,1,0
1,-4.7,hsa04722,Neurotrophin signaling pathway,M1,1,0
1,-4.8,R-HSA-76002,"Platelet activation, signaling and aggregation",M1,1,0
1,-5.8,GO:0006873,intracellular monoatomic ion homeostasis,M1,1,0
1,-6.9,GO:0030100,regulation of endocytosis,M1,1,0
1,-4.6,GO:0038093,Fc receptor signaling pathway,M1,1,0
1,-5.5,hsa05416,Viral myocarditis,M1,1,0
1,-2.4,GO:0044283,small molecule biosynthetic process,M1,1,0
1,-6,GO:0032774,RNA biosynthetic process,M1,1,0
1,-2.1,GO:0071709,membrane assembly,M1,1,0
1,-7.6,GO:0048871,multicellular organismal-level homeostasis,M1,1,0
1,-3,WP4239,Epithelial to mesenchymal transition in colorectal cancer,M1,1,0
1,-2.2,GO:0071385,cellular response to glucocorticoid stimulus,M1,1,0
1,-2.4,hsa04970,Salivary secretion,M1,1,0
1,-2.8,WP5321,Prostaglandin and leukotriene metabolism in senescence,M1,1,0
1,-2.7,GDP04228,Lymphocytic Leukemia,M1,1,0
1,-2.6,GDP01504,Congenital Epicanthus,M1,1,0
1,-3.4,GO:1902041,regulation of extrinsic apoptotic signaling pathway via death domain receptors,M1,1,0
1,-2.3,GO:0007188,adenylate cyclase-modulating G protein-coupled receptor signaling pathway,M1,1,0
1,-2.8,hsa00562,Inositol phosphate metabolism,M1,1,0
1,-8.5,GDP03928,Kidney Failure,M1,1,0
1,-5.1,R-HSA-400253,Circadian Clock,M1,1,0
1,-4,GO:1901796,regulation of signal transduction by p53 class mediator,M1,1,0
1,-5,GO:0007200,phospholipase C-activating G protein-coupled receptor signaling pathway,M1,1,0
1,-4.9,GO:0009746,response to hexose,M1,1,0
1,-2.1,R-HSA-73894,DNA Repair,M1,1,0
1,-3.1,GO:0046824,positive regulation of nucleocytoplasmic transport,M1,1,0
1,-4.5,hsa05235,PD-L1 expression and PD-1 checkpoint pathway in cancer,M1,1,0
1,-2.5,GO:0086065,cell communication involved in cardiac conduction,M1,1,0
1,-3.5,GO:1901861,regulation of muscle tissue development,M1,1,0
1,-12,GO:0070201,regulation of establishment of protein localization,M1,1,0
1,-2.3,GO:0046649,lymphocyte activation,M1,1,0
1,-2.2,R-HSA-168181,Toll Like Receptor 7/8 (TLR7/8) Cascade,M1,1,0
1,-3,M279,PID RB 1PATHWAY,M1,1,0
1,-6.3,GO:0000302,response to reactive oxygen species,M1,1,0
1,-14,GO:0043408,regulation of MAPK cascade,M1,1,0
1,-2.8,GO:1905145,cellular response to acetylcholine,M1,1,0
1,-3.4,R-HSA-2428928,IRS-related events triggered by IGF1R,M1,1,0
1,-3.1,hsa04150,mTOR signaling pathway,M1,1,0
1,-3.4,GDP03967,LEOPARD Syndrome,M1,1,0
1,-3,GO:0070723,response to cholesterol,M1,1,0
1,-4.4,GO:0051224,negative regulation of protein transport,M1,1,0
1,-5,GO:0098659,inorganic cation import across plasma membrane,M1,1,0
1,-2.4,R-HSA-9013423,RAC3 GTPase cycle,M1,1,0
1,-13,GO:1902074,response to salt,M1,1,0
1,-3.3,WP5046,NAD metabolism in oncogene-induced senescence and mitochondrial dysfunction-associated senescence,M1,1,0
1,-5,GO:0099587,inorganic ion import across plasma membrane,M1,1,0
1,-2.6,WP1433,Nucleotide-binding oligomerization domain (NOD) pathway,M1,1,0
1,-3.2,GO:0032768,regulation of monooxygenase activity,M1,1,0
1,-3.9,hsa05207,Chemical carcinogenesis - receptor activation,M1,1,0
1,-7.6,GO:0090257,regulation of muscle system process,M1,1,0
1,-2.3,GO:1990823,response to leukemia inhibitory factor,M1,1,0
1,-2.3,GO:0045761,regulation of adenylate cyclase activity,M1,1,0
1,-5.2,GO:0043405,regulation of MAP kinase activity,M1,1,0
1,-2.2,GO:1901617,organic hydroxy compound biosynthetic process,M1,1,0
1,-2.9,GO:0008203,cholesterol metabolic process,M1,1,0
1,-3.6,R-HSA-109704,PI3K Cascade,M1,1,0
1,-7.4,GO:0010563,negative regulation of phosphorus metabolic process,M1,1,0
1,-3.1,GO:0042306,regulation of protein import into nucleus,M1,1,0
1,-6.1,R-HSA-2990846,SUMOylation,M1,1,0
1,-4.6,R-HSA-1280218,Adaptive Immune System,M1,1,0
1,-3.1,GO:0019934,cGMP-mediated signaling,M1,1,0
1,-2.3,GO:0015698,inorganic anion transport,M1,1,0
1,-7.2,GO:0031669,cellular response to nutrient levels,M1,1,0
1,-8.5,GO:0098662,inorganic cation transmembrane transport,M1,1,0
1,-5.7,GDP04568,Metastatic Melanoma,M1,1,0
1,-3.4,GO:0030516,regulation of axon extension,M1,1,0
1,-4.8,GO:1902894,negative regulation of miRNA transcription,M1,1,0
1,-4,GO:0140352,export from cell,M1,1,0
1,-2.6,GDP06846,Subarachnoid hemorrhage,M1,1,0
1,-2.2,GO:0051341,regulation of oxidoreductase activity,M1,1,0
1,-4.9,GO:0048662,negative regulation of smooth muscle cell proliferation,M1,1,0
1,-2.8,GO:0009064,glutamine family amino acid metabolic process,M1,1,0
1,-3.5,R-HSA-9670439,"Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants",M1,1,0
1,-4.4,GO:0032535,regulation of cellular component size,M1,1,0
1,-2.2,GO:1990778,protein localization to cell periphery,M1,1,0
1,-9.6,hsa04931,Insulin resistance,M1,1,0
1,-2.2,hsa05164,Influenza A,M1,1,0
1,-4.2,GO:0150063,visual system development,M1,1,0
1,-4.6,GO:0007411,axon guidance,M1,1,0
1,-5.8,GO:0050871,positive regulation of B cell activation,M1,1,0
1,-2.5,GO:0007611,learning or memory,M1,1,0
1,-2.3,R-HSA-383280,Nuclear Receptor transcription pathway,M1,1,0
1,-3.9,GO:0030307,positive regulation of cell growth,M1,1,0
1,-4.7,GO:0007369,gastrulation,M1,1,0
1,-12,GO:0045785,positive regulation of cell adhesion,M1,1,0
1,-4.3,R-HSA-4755510,SUMOylation of immune response proteins,M1,1,0
1,-6.6,hsa05225,Hepatocellular carcinoma,M1,1,0
1,-3.9,GO:0098916,anterograde trans-synaptic signaling,M1,1,0
1,-9.6,hsa04015,Rap1 signaling pathway,M1,1,0
1,-5.5,GDP02039,Developmental regression,M1,1,0
1,-8.6,R-HSA-9006931,Signaling by Nuclear Receptors,M1,1,0
1,-4.3,GO:0045736,negative regulation of cyclin-dependent protein serine/threonine kinase activity,M1,1,0
1,-4.9,WP4674,Head and neck squamous cell carcinoma,M1,1,0
1,-5.9,GDP02828,Glioblastoma,M1,1,0
1,-3.3,R-HSA-112409,RAF-independent MAPK1/3 activation,M1,1,0
1,-4,R-HSA-399955,SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion,M1,1,0
1,-6.2,GO:0120035,regulation of plasma membrane bounded cell projection organization,M1,1,0
1,-3.9,GO:0033500,carbohydrate homeostasis,M1,1,0
1,-8.6,hsa05220,Chronic myeloid leukemia,M1,1,0
1,-2.4,GO:0019915,lipid storage,M1,1,0
1,-2.7,GDP01597,Congenital Pectus Carinatum,M1,1,0
1,-2.8,GO:0071675,regulation of mononuclear cell migration,M1,1,0
1,-2.4,GO:0006820,monoatomic anion transport,M1,1,0
1,-4,GO:0002021,response to dietary excess,M1,1,0
1,-2.2,M88,PID CD8 TCR PATHWAY,M1,1,0
1,-3.1,GO:0031279,regulation of cyclase activity,M1,1,0
1,-10,GO:0034762,regulation of transmembrane transport,M1,1,0
1,-2.8,GO:0006611,protein export from nucleus,M1,1,0
1,-3.7,GO:0031294,lymphocyte costimulation,M1,1,0
1,-2.8,R-HSA-388396,GPCR downstream signalling,M1,1,0
1,-5.1,GO:0043068,positive regulation of programmed cell death,M1,1,0
1,-9,GO:0030162,regulation of proteolysis,M1,1,0
1,-3.5,GO:0071456,cellular response to hypoxia,M1,1,0
1,-2.4,GO:1904705,regulation of vascular associated smooth muscle cell proliferation,M1,1,0
1,-2.1,GO:0007586,digestion,M1,1,0
1,-3.6,R-HSA-1168372,Downstream signaling events of B Cell Receptor (BCR),M1,1,0
1,-5.5,GDP04173,Liver Fibrosis,M1,1,0
1,-4.2,R-HSA-2029481,FCGR activation,M1,1,0
1,-8.1,hsa05210,Colorectal cancer,M1,1,0
1,-5.1,GO:0009617,response to bacterium,M1,1,0
1,-17,GO:0008015,blood circulation,M1,1,0
1,-5.1,R-HSA-8856828,Clathrin-mediated endocytosis,M1,1,0
1,-3.8,GO:0043267,negative regulation of potassium ion transport,M1,1,0
1,-3.2,WP1539,Angiogenesis,M1,1,0
1,-8.3,GO:0035296,regulation of tube diameter,M1,1,0
1,-3.5,GDP00800,Biliary Cholangitis,M1,1,0
1,-3.4,GO:0007623,circadian rhythm,M1,1,0
1,-3.6,WP3670,Interactions between LOXL4 and oxidative stress pathway,M1,1,0
1,-3.2,R-HSA-9018519,Estrogen-dependent gene expression,M1,1,0
1,-5.5,GO:1900182,positive regulation of protein localization to nucleus,M1,1,0
1,-5.2,GO:2000811,negative regulation of anoikis,M1,1,0
1,-2.8,GO:1901380,negative regulation of potassium ion transmembrane transport,M1,1,0
1,-2.9,M23,PID WNT NONCANONICAL PATHWAY,M1,1,0
1,-2.6,GDP06186,Renal Glomerular Disease,M1,1,0
1,-4.2,GO:2000630,positive regulation of miRNA metabolic process,M1,1,0
1,-6.5,GO:0050778,positive regulation of immune response,M1,1,0
1,-3.9,GDP06658,Spasms Syndrome,M1,1,0
1,-2.4,GO:0055010,ventricular cardiac muscle tissue morphogenesis,M1,1,0
1,-13,GO:0071363,cellular response to growth factor stimulus,M1,1,0
1,-4.7,WP4549,Fragile X syndrome,M1,1,0
1,-4.3,R-HSA-9692914,SARS-CoV-1-host interactions,M1,1,0
1,-3,R-HSA-2672351,Stimuli-sensing channels,M1,1,0
1,-4.8,M19,PID P73PATHWAY,M1,1,0
1,-9.1,GO:0001558,regulation of cell growth,M1,1,0
1,-6.7,GDP00399,Anaplastic Carcinoma,M1,1,0
1,-5.3,GO:0008360,regulation of cell shape,M1,1,0
1,-2.1,GO:0031570,DNA integrity checkpoint signaling,M1,1,0
1,-2.3,R-HSA-975138,TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation,M1,1,0
1,-6.3,hsa05010,Alzheimer disease,M1,1,0
1,-6.4,GO:1902532,negative regulation of intracellular signal transduction,M1,1,0
1,-7.2,GO:0099177,regulation of trans-synaptic signaling,M1,1,0
1,-3.7,GO:0090278,negative regulation of peptide hormone secretion,M1,1,0
1,-2.5,GDP03633,Inflammatory Bowel Disease,M1,1,0
1,-2.9,WP5323,Fatty Acids and Lipoproteins Transport in Hepatocytes,M1,1,0
1,-3.6,GO:1905475,regulation of protein localization to membrane,M1,1,0
1,-8.6,M50,PID PTP1B PATHWAY,M1,1,0
1,-2.1,GO:0043470,regulation of carbohydrate catabolic process,M1,1,0
1,-5.2,GO:0031589,cell-substrate adhesion,M1,1,0
1,-4.9,GDP04169,Liver Cirrhosis,M1,1,0
1,-2.3,R-HSA-168142,Toll Like Receptor 10 (TLR10) Cascade,M1,1,0
1,-2.7,GO:0002758,innate immune response-activating signaling pathway,M1,1,0
1,-4,GO:0090596,sensory organ morphogenesis,M1,1,0
1,-2.4,hsa04973,Carbohydrate digestion and absorption,M1,1,0
1,-5.4,GO:0010634,positive regulation of epithelial cell migration,M1,1,0
1,-3.8,GO:0071479,cellular response to ionizing radiation,M1,1,0
1,-3.1,GO:0097193,intrinsic apoptotic signaling pathway,M1,1,0
1,-3.4,GO:0007213,G protein-coupled acetylcholine receptor signaling pathway,M1,1,0
1,-8.6,GO:0097305,response to alcohol,M1,1,0
1,-2.4,R-HSA-9649948,Signaling downstream of RAS mutants,M1,1,0
1,-3.1,GDP06182,Renal Carcinoma,M1,1,0
1,-3.2,GO:0050768,negative regulation of neurogenesis,M1,1,0
1,-2.7,R-HSA-6802948,Signaling by high-kinase activity BRAF mutants,M1,1,0
1,-2.3,GO:0051646,mitochondrion localization,M1,1,0
1,-3.1,GO:0010906,regulation of glucose metabolic process,M1,1,0
1,-5.2,GO:0048608,reproductive structure development,M1,1,0
1,-2.6,GDP00353,Alveolitis,M1,1,0
1,-2.3,WP1530,miRNA regulation of DNA damage response,M1,1,0
1,-7.6,GO:0032102,negative regulation of response to external stimulus,M1,1,0
1,-2.1,GO:0006939,smooth muscle contraction,M1,1,0
1,-2.3,GO:0048546,digestive tract morphogenesis,M1,1,0
1,-5.3,GO:0090218,positive regulation of lipid kinase activity,M1,1,0
1,-6.2,GO:0060070,canonical Wnt signaling pathway,M1,1,0
1,-3.6,GO:0007043,cell-cell junction assembly,M1,1,0
1,-5.6,GO:0055001,muscle cell development,M1,1,0
1,-2.5,GO:2001235,positive regulation of apoptotic signaling pathway,M1,1,0
1,-11,GO:0008217,regulation of blood pressure,M1,1,0
1,-5.3,GDP02336,Endometrial Cancer,M1,1,0
1,-3.9,R-HSA-983705,Signaling by the B Cell Receptor (BCR),M1,1,0
1,-10,GO:0010810,regulation of cell-substrate adhesion,M1,1,0
1,-5,GO:1902075,cellular response to salt,M1,1,0
1,-3,GO:0070306,lens fiber cell differentiation,M1,1,0
1,-3,GDP06958,Talipes Transversoplanus,M1,1,0
1,-3.4,GO:0001701,in utero embryonic development,M1,1,0
1,-3.5,GO:0044843,cell cycle G1/S phase transition,M1,1,0
1,-3.4,M206,PID PDGFRA PATHWAY,M1,1,0
1,-3.1,R-HSA-211945,Phase I - Functionalization of compounds,M1,1,0
1,-2.2,GO:0071322,cellular response to carbohydrate stimulus,M1,1,0
1,-2.7,GDP03274,Hydronephrosis,M1,1,0
1,-2.9,GDP00804,Biliary cirrhosis,M1,1,0
1,-2.1,GO:0006821,chloride transport,M1,1,0
1,-4.3,WP3844,PI3K-AKT-mTOR signaling pathway and therapeutic opportunities,M1,1,0
1,-3.2,GO:0043062,extracellular structure organization,M1,1,0
1,-7.5,GO:1903829,positive regulation of protein localization,M1,1,0
1,-12,GO:0061061,muscle structure development,M1,1,0
1,-4.7,GO:0030522,intracellular receptor signaling pathway,M1,1,0
1,-2.5,GO:0046546,development of primary male sexual characteristics,M1,1,0
1,-3.5,GO:0000082,G1/S transition of mitotic cell cycle,M1,1,0
1,-3.3,GO:0010883,regulation of lipid storage,M1,1,0
1,-4.3,GO:1903169,regulation of calcium ion transmembrane transport,M1,1,0
1,-5.1,GO:0051668,localization within membrane,M1,1,0
1,-5.7,GO:0035051,cardiocyte differentiation,M1,1,0
1,-8.3,GO:0097746,blood vessel diameter maintenance,M1,1,0
1,-2.6,WP2516,ATM signaling pathway,M1,1,0
1,-6.3,GO:0008283,cell population proliferation,M1,1,0
1,-4.9,GO:0042330,taxis,M1,1,0
1,-3.9,R-HSA-9013026,RHOB GTPase cycle,M1,1,0
1,-4.1,R-HSA-4791275,Signaling by WNT in cancer,M1,1,0
1,-3.6,GO:0046683,response to organophosphorus,M1,1,0
1,-2.2,GO:0072330,monocarboxylic acid biosynthetic process,M1,1,0
1,-10,GO:1905114,cell surface receptor signaling pathway involved in cell-cell signaling,M1,1,0
1,-14,GO:0051046,regulation of secretion,M1,1,0
1,-2.9,GO:0001704,formation of primary germ layer,M1,1,0
1,-2.5,GO:1900407,regulation of cellular response to oxidative stress,M1,1,0
1,-4.5,GO:0002026,regulation of the force of heart contraction,M1,1,0
1,-6.1,GO:0033138,positive regulation of peptidyl-serine phosphorylation,M1,1,0
1,-4,GDP01839,Cryptorchidism,M1,1,0
1,-2.5,R-HSA-9656223,Signaling by RAF1 mutants,M1,1,0
1,-13,GO:1903530,regulation of secretion by cell,M1,1,0
1,-4.8,GO:0060828,regulation of canonical Wnt signaling pathway,M1,1,0
1,-4.5,R-HSA-162906,HIV Infection,M1,1,0
1,-3.9,GO:0051100,negative regulation of binding,M1,1,0
1,-3,GO:0034109,homotypic cell-cell adhesion,M1,1,0
1,-3.6,GDP04385,Malignant neoplasm of salivary gland,M1,1,0
1,-2.9,GO:0048741,skeletal muscle fiber development,M1,1,0
1,-6.8,GO:2001236,regulation of extrinsic apoptotic signaling pathway,M1,1,0
1,-7.4,GO:0048660,regulation of smooth muscle cell proliferation,M1,1,0
1,-2.1,GO:0097237,cellular response to toxic substance,M1,1,0
1,-7.3,GO:0006979,response to oxidative stress,M1,1,0
1,-4.2,GO:2000463,positive regulation of excitatory postsynaptic potential,M1,1,0
1,-4.3,GO:1901379,regulation of potassium ion transmembrane transport,M1,1,0
1,-3.9,GO:0046718,viral entry into host cell,M1,1,0
1,-2.7,GO:0001501,skeletal system development,M1,1,0
1,-2.2,R-HSA-168643,"Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways",M1,1,0
1,-4.9,GO:0048015,phosphatidylinositol-mediated signaling,M1,1,0
1,-4.4,GO:0007160,cell-matrix adhesion,M1,1,0
1,-2.7,GO:0032885,regulation of polysaccharide biosynthetic process,M1,1,0
1,-3.5,GO:0003094,glomerular filtration,M1,1,0
1,-2.7,GO:0018205,peptidyl-lysine modification,M1,1,0
1,-9.2,GO:0051348,negative regulation of transferase activity,M1,1,0
1,-6.3,GO:0045088,regulation of innate immune response,M1,1,0
1,-4.5,GO:0002429,immune response-activating cell surface receptor signaling pathway,M1,1,0
1,-5.5,GO:2000058,regulation of ubiquitin-dependent protein catabolic process,M1,1,0
1,-2.1,R-HSA-3000171,Non-integrin membrane-ECM interactions,M1,1,0
1,-14,GO:0006468,protein phosphorylation,M1,1,0
1,-3.3,GDP04393,Malocclusion,M1,1,0
1,-4,GO:1903531,negative regulation of secretion by cell,M1,1,0
1,-5.2,hsa04020,Calcium signaling pathway,M1,1,0
1,-16,GO:0007167,enzyme-linked receptor protein signaling pathway,M1,1,0
1,-2.8,M210,PID IL8 CXCR2 PATHWAY,M1,1,0
1,-3.9,GO:0045732,positive regulation of protein catabolic process,M1,1,0
1,-12,WP138,Androgen receptor signaling pathway,M1,1,0
1,-4.4,R-HSA-166520,Signaling by NTRKs,M1,1,0
1,-2.3,hsa04972,Pancreatic secretion,M1,1,0
1,-12,GO:0051047,positive regulation of secretion,M1,1,0
1,-7.8,M15,PID LYSOPHOSPHOLIPID PATHWAY,M1,1,0
1,-2.2,WP395,IL-4 signaling pathway,M1,1,0
1,-3.3,R-HSA-2428924,IGF1R signaling cascade,M1,1,0
1,-4.3,R-HSA-4090294,SUMOylation of intracellular receptors,M1,1,0
1,-13,GO:0040017,positive regulation of locomotion,M1,1,0
1,-9,GO:0001944,vasculature development,M1,1,0
1,-5.5,GO:0055007,cardiac muscle cell differentiation,M1,1,0
1,-5.6,GO:0045596,negative regulation of cell differentiation,M1,1,0
1,-2.4,GO:0061005,cell differentiation involved in kidney development,M1,1,0
1,-3,GO:0061138,morphogenesis of a branching epithelium,M1,1,0
1,-5,M90,PID WNT CANONICAL PATHWAY,M1,1,0
1,-4.5,M32,PID HDAC CLASSIII PATHWAY,M1,1,0
1,-2.1,GO:0051898,negative regulation of protein kinase B signaling,M1,1,0
1,-6.1,GO:0090277,positive regulation of peptide hormone secretion,M1,1,0
1,-11,hsa04151,PI3K-Akt signaling pathway,M1,1,0
1,-3,GO:0046942,carboxylic acid transport,M1,1,0
1,-7,GO:0014066,regulation of phosphatidylinositol 3-kinase signaling,M1,1,0
1,-2.1,GDP04207,Lung adenocarcinoma,M1,1,0
1,-3.7,GO:0048762,mesenchymal cell differentiation,M1,1,0
1,-3,M72,PID NECTIN PATHWAY,M1,1,0
1,-2.2,R-HSA-168138,Toll Like Receptor 9 (TLR9) Cascade,M1,1,0
1,-3.6,GO:0051493,regulation of cytoskeleton organization,M1,1,0
1,-8.2,hsa05213,Endometrial cancer,M1,1,0
1,-8,GO:0090276,regulation of peptide hormone secretion,M1,1,0
1,-7.7,R-HSA-9675108,Nervous system development,M1,1,0
1,-2.9,GO:0048640,negative regulation of developmental growth,M1,1,0
1,-3.4,GO:0048013,ephrin receptor signaling pathway,M1,1,0
1,-4.8,R-HSA-912631,Regulation of signaling by CBL,M1,1,0
1,-2.3,GO:1990830,cellular response to leukemia inhibitory factor,M1,1,0
1,-2.1,GDP07030,Thoracic Aortic Aneurysm And Aortic Dissection,M1,1,0
1,-3.8,GO:0001666,response to hypoxia,M1,1,0
1,-3.4,GDP04811,Multiple Congenital Anomalies,M1,1,0
1,-4.1,GO:0071248,cellular response to metal ion,M1,1,0
1,-2.6,M41,PID ER NONGENOMIC PATHWAY,M1,1,0
1,-5.1,GO:0150116,regulation of cell-substrate junction organization,M1,1,0
1,-3.3,GO:0014074,response to purine-containing compound,M1,1,0
1,-2.9,R-HSA-1251985,Nuclear signaling by ERBB4,M1,1,0
1,-2.6,GO:0090287,regulation of cellular response to growth factor stimulus,M1,1,0
1,-3.3,GO:0010001,glial cell differentiation,M1,1,0
1,-4.3,GO:1904950,negative regulation of establishment of protein localization,M1,1,0
1,-3.4,GDP00821,Bladder Neoplasm,M1,1,0
1,-4.3,GO:1900180,regulation of protein localization to nucleus,M1,1,0
1,-2.6,R-HSA-381340,Transcriptional regulation of white adipocyte differentiation,M1,1,0
1,-2.6,GO:0051149,positive regulation of muscle cell differentiation,M1,1,0
1,-3.8,GO:2000116,regulation of cysteine-type endopeptidase activity,M1,1,0
1,-6.6,R-HSA-556833,Metabolism of lipids,M1,1,0
1,-2.9,GO:0043406,positive regulation of MAP kinase activity,M1,1,0
1,-2.9,hsa05211,Renal cell carcinoma,M1,1,0
1,-5.7,R-HSA-194315,Signaling by Rho GTPases,M1,1,0
1,-3.9,R-HSA-9735871,SARS-CoV-1 targets host intracellular signalling and regulatory pathways,M1,1,0
1,-3.2,GO:1904666,regulation of ubiquitin protein ligase activity,M1,1,0
1,-2.8,hsa05022,Pathways of neurodegeneration - multiple diseases,M1,1,0
1,-5.8,GO:0031329,regulation of cellular catabolic process,M1,1,0
1,-13,GO:0035239,tube morphogenesis,M1,1,0
1,-2,GDP05576,Parkinson Disease,M1,1,0
1,-2.6,GO:0019722,calcium-mediated signaling,M1,1,0
1,-5.6,WP4263,Pancreatic adenocarcinoma pathway,M1,1,0
1,-3.5,GO:0010766,negative regulation of sodium ion transport,M1,1,0
1,-5,GDP05006,Nasopharyngeal Carcinoma,M1,1,0
1,-5.2,GO:0070167,regulation of biomineral tissue development,M1,1,0
1,-3.7,GDP02569,Fatty Liver,M1,1,0
1,-2.6,GO:0055078,sodium ion homeostasis,M1,1,0
1,-4.3,GO:0001101,response to acid chemical,M1,1,0
1,-9.1,GO:0060627,regulation of vesicle-mediated transport,M1,1,0
1,-3.9,GO:0007416,synapse assembly,M1,1,0
1,-2.3,R-HSA-5688426,Deubiquitination,M1,1,0
1,-6,hsa05212,Pancreatic cancer,M1,1,0
1,-2.4,GO:0120161,regulation of cold-induced thermogenesis,M1,1,0
1,-12,GO:0040008,regulation of growth,M1,1,0
1,-3.3,WP560,TGF-beta receptor signaling,M1,1,0
1,-5,GDP02345,Endometriosis,M1,1,0
1,-2.2,R-HSA-937061,TRIF(TICAM1)-mediated TLR4 signaling,M1,1,0
1,-2.3,GO:0060324,face development,M1,1,0
1,-2.9,GO:0006694,steroid biosynthetic process,M1,1,0
1,-4.4,GO:0099537,trans-synaptic signaling,M1,1,0
1,-4.5,WP585,Interferon type I signaling pathways,M1,1,0
1,-2.5,M144,PID CERAMIDE PATHWAY,M1,1,0
1,-3.4,GO:2000725,regulation of cardiac muscle cell differentiation,M1,1,0
1,-3.1,GO:0002027,regulation of heart rate,M1,1,0
1,-6.2,GO:2000209,regulation of anoikis,M1,1,0
1,-2.1,GO:0098773,skin epidermis development,M1,1,0
1,-2.8,GO:0032922,circadian regulation of gene expression,M1,1,0
1,-3.6,GDP00643,Autoimmune Diabetes,M1,1,0
1,-4.7,GO:0030036,actin cytoskeleton organization,M1,1,0
1,-3.2,WP3668,Hypothesized pathways in pathogenesis of cardiovascular disease,M1,1,0
1,-3.9,GO:0061564,axon development,M1,1,0
1,-4.9,GO:0006935,chemotaxis,M1,1,0
1,-2.2,GO:0110020,regulation of actomyosin structure organization,M1,1,0
1,-3.2,R-HSA-9006115,Signaling by NTRK2 (TRKB),M1,1,0
1,-2.4,GO:0051962,positive regulation of nervous system development,M1,1,0
1,-2.7,GO:0052548,regulation of endopeptidase activity,M1,1,0
1,-4,GO:0033598,mammary gland epithelial cell proliferation,M1,1,0
1,-2.6,GO:0009895,negative regulation of catabolic process,M1,1,0
1,-5.6,WP3995,Prion disease pathway,M1,1,0
1,-2.1,GO:0042752,regulation of circadian rhythm,M1,1,0
1,-15,GO:0042327,positive regulation of phosphorylation,M1,1,0
1,-4.8,hsa05412,Arrhythmogenic right ventricular cardiomyopathy,M1,1,0
1,-2.6,GDP06247,Retinal Diseases,M1,1,0
1,-2.7,R-HSA-2129379,Molecules associated with elastic fibres,M1,1,0
1,-4.4,hsa04014,Ras signaling pathway,M1,1,0
1,-5.6,hsa05417,Lipid and atherosclerosis,M1,1,0
1,-9.3,GDP02340,Endometrial Neoplasms,M1,1,0
1,-2.2,GO:0007034,vacuolar transport,M1,1,0
1,-4,GO:0043010,camera-type eye development,M1,1,0
1,-3.6,GO:0030500,regulation of bone mineralization,M1,1,0
1,-9.1,GO:0045444,fat cell differentiation,M1,1,0
1,-2.9,GO:0033198,response to ATP,M1,1,0
1,-2.9,GO:0010039,response to iron ion,M1,1,0
1,-3,GO:1905954,positive regulation of lipid localization,M1,1,0
1,-3.5,WP254,Apoptosis,M1,1,0
1,-3.4,GO:0072012,glomerulus vasculature development,M1,1,0
1,-6.8,R-HSA-9664422,FCGR3A-mediated phagocytosis,M1,1,0
1,-5.5,WP4336,ncRNAs involved in Wnt signaling in hepatocellular carcinoma,M1,1,0
1,-2.6,GO:0042770,signal transduction in response to DNA damage,M1,1,0
1,-5.8,M76,PID P38 ALPHA BETA PATHWAY,M1,1,0
1,-2.2,M164,PID ERBB1 DOWNSTREAM PATHWAY,M1,1,0
1,-3.4,GDP03531,Hypotonic seizures,M1,1,0
1,-4,hsa04261,Adrenergic signaling in cardiomyocytes,M1,1,0
1,-3,GO:0055013,cardiac muscle cell development,M1,1,0
1,-3.3,GO:0035561,regulation of chromatin binding,M1,1,0
1,-3.3,GO:0071345,cellular response to cytokine stimulus,M1,1,0
1,-3.2,R-HSA-162587,HIV Life Cycle,M1,1,0
1,-2.5,GO:0006366,transcription by RNA polymerase II,M1,1,0
1,-2.7,GDP05799,Pituitary adenoma,M1,1,0
1,-7.6,GDP01700,Congestive Heart Failure,M1,1,0
1,-5.1,GO:1901214,regulation of neuron death,M1,1,0
1,-5.5,R-HSA-203641,NOSTRIN mediated eNOS trafficking,M1,1,0
1,-3.2,GO:0010866,regulation of triglyceride biosynthetic process,M1,1,0
1,-4.1,WP2817,Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4),M1,1,0
1,-11,GO:0061041,regulation of wound healing,M1,1,0
1,-2.5,GO:0043588,skin development,M1,1,0
1,-3,GO:0046822,regulation of nucleocytoplasmic transport,M1,1,0
1,-3.8,GO:0022407,regulation of cell-cell adhesion,M1,1,0
1,-2.8,R-HSA-9634815,Transcriptional Regulation by NPAS4,M1,1,0
1,-2.1,GDP01903,Dandy-Walker Syndrome,M1,1,0
1,-7,GO:0032024,positive regulation of insulin secretion,M1,1,0
1,-2.3,WP2064,Neural crest differentiation,M1,1,0
1,-5.7,WP2882,Nuclear receptors meta-pathway,M1,1,0
1,-5,hsa05218,Melanoma,M1,1,0
1,-2.6,GO:0010863,positive regulation of phospholipase C activity,M1,1,0
1,-6.1,GO:0062012,regulation of small molecule metabolic process,M1,1,0
1,-3.4,GO:0070482,response to oxygen levels,M1,1,0
1,-9.6,GO:1903034,regulation of response to wounding,M1,1,0
1,-6.1,GO:0048812,neuron projection morphogenesis,M1,1,0
1,-7.9,GO:0002791,regulation of peptide secretion,M1,1,0
1,-3.2,GDP03080,Hepatocellular adenoma,M1,1,0
1,-2.2,R-HSA-9700206,Signaling by ALK in cancer,M1,1,0
1,-2.6,M176,PID FOXM1 PATHWAY,M1,1,0
1,-2.7,WP4844,Influence of laminopathies on Wnt signaling,M1,1,0
1,-3.1,GO:0051701,biological process involved in interaction with host,M1,1,0
1,-4,GO:0044403,biological process involved in symbiotic interaction,M1,1,0
1,-2.1,GO:1903078,positive regulation of protein localization to plasma membrane,M1,1,0
1,-2.2,hsa04530,Tight junction,M1,1,0
1,-5.2,GO:0032376,positive regulation of cholesterol transport,M1,1,0
1,-4.7,GO:0016311,dephosphorylation,M1,1,0
1,-3.5,WP4657,22q11.2 copy number variation syndrome,M1,1,0
1,-2.1,GDP06621,Skin cancer,M1,1,0
1,-4.5,GO:0006813,potassium ion transport,M1,1,0
1,-2.3,R-HSA-168176,Toll Like Receptor 5 (TLR5) Cascade,M1,1,0
1,-2.5,R-HSA-1566948,Elastic fibre formation,M1,1,0
1,-3.4,GO:0071731,response to nitric oxide,M1,1,0
1,-8,R-HSA-422475,Axon guidance,M1,1,0
1,-4.4,GDP05616,Patent ductus arteriosus,M1,1,0
1,-2.2,hsa04340,Hedgehog signaling pathway,M1,1,0
1,-7.3,GO:0030336,negative regulation of cell migration,M1,1,0
1,-5.2,WP2324,AGE/RAGE pathway,M1,1,0
1,-3.9,GO:1903039,positive regulation of leukocyte cell-cell adhesion,M1,1,0
1,-3.3,R-HSA-5621481,C-type lectin receptors (CLRs),M1,1,0
1,-2.4,GO:0099003,vesicle-mediated transport in synapse,M1,1,0
1,-3.5,GO:1904375,regulation of protein localization to cell periphery,M1,1,0
1,-7.9,GO:0090087,regulation of peptide transport,M1,1,0
1,-2.2,R-HSA-975155,MyD88 dependent cascade initiated on endosome,M1,1,0
1,-5.1,GO:0061458,reproductive system development,M1,1,0
1,-2.4,R-HSA-6802949,Signaling by RAS mutants,M1,1,0
1,-2.4,R-HSA-376176,Signaling by ROBO receptors,M1,1,0
1,-3.7,GDP01857,Cutis marmorata,M1,1,0
1,-2.5,R-HSA-2173782,Binding and Uptake of Ligands by Scavenger Receptors,M1,1,0
1,-2.6,R-HSA-5674135,MAP2K and MAPK activation,M1,1,0
1,-5.9,GO:0050678,regulation of epithelial cell proliferation,M1,1,0
1,-4.4,WP4630,Measles virus infection,M1,1,0
1,-3.3,M276,PID FGF PATHWAY,M1,1,0
1,-3.1,GO:0001841,neural tube formation,M1,1,0
1,-2.5,GO:0016331,morphogenesis of embryonic epithelium,M1,1,0
1,-2,GO:0043161,proteasome-mediated ubiquitin-dependent protein catabolic process,M1,1,0
1,-2.4,GO:0042303,molting cycle,M1,1,0
1,-5.1,GO:0031331,positive regulation of cellular catabolic process,M1,1,0
1,-7.4,WP399,Wnt signaling pathway and pluripotency,M1,1,0
1,-7.4,WP5124,Alzheimer's disease,M1,1,0
1,-2.2,GO:0072332,intrinsic apoptotic signaling pathway by p53 class mediator,M1,1,0
1,-3.2,GO:0043255,regulation of carbohydrate biosynthetic process,M1,1,0
1,-7.6,GO:0006469,negative regulation of protein kinase activity,M1,1,0
1,-3.3,R-HSA-9013409,RHOJ GTPase cycle,M1,1,0
1,-4.6,WP3611,Photodynamic therapy-induced AP-1 survival signaling,M1,1,0
1,-3,GO:0006936,muscle contraction,M1,1,0
1,-4.7,GO:0040011,locomotion,M1,1,0
1,-3.5,GO:0006913,nucleocytoplasmic transport,M1,1,0
1,-5.9,GO:0010942,positive regulation of cell death,M1,1,0
1,-2.6,GO:0048753,pigment granule organization,M1,1,0
1,-3.3,GO:0050921,positive regulation of chemotaxis,M1,1,0
1,-3.7,GO:0007423,sensory organ development,M1,1,0
1,-5.1,M159,PID AMB2 NEUTROPHILS PATHWAY,M1,1,0
1,-3.8,GO:0010506,regulation of autophagy,M1,1,0
1,-4.2,R-HSA-9678108,SARS-CoV-1 Infection,M1,1,0
1,-6,GO:0060485,mesenchyme development,M1,1,0
1,-13,WP710,DNA damage response (only ATM dependent),M1,1,0
1,-2.2,GO:0032526,response to retinoic acid,M1,1,0
1,-3.2,GO:0032956,regulation of actin cytoskeleton organization,M1,1,0
1,-3.6,GO:1901216,positive regulation of neuron death,M1,1,0
1,-7.9,GO:0048545,response to steroid hormone,M1,1,0
1,-2.3,GDP02897,Gouty arthritis,M1,1,0
1,-2.9,GO:0050769,positive regulation of neurogenesis,M1,1,0
1,-3,GDP02989,Hearing Loss,M1,1,0
1,-2.8,M127,PID ERBB1 RECEPTOR PROXIMAL PATHWAY,M1,1,0
1,-4.6,R-HSA-5674400,Constitutive Signaling by AKT1 E17K in Cancer,M1,1,0
1,-6.6,GO:0008016,regulation of heart contraction,M1,1,0
1,-2.3,R-HSA-1227986,Signaling by ERBB2,M1,1,0
1,-2.5,R-HSA-1660661,Sphingolipid de novo biosynthesis,M1,1,0
1,-2.3,hsa04916,Melanogenesis,M1,1,0
1,-6.8,R-HSA-425407,SLC-mediated transmembrane transport,M1,1,0
1,-3.9,hsa04960,Aldosterone-regulated sodium reabsorption,M1,1,0
1,-6,GO:0010564,regulation of cell cycle process,M1,1,0
1,-3.6,GO:0051301,cell division,M1,1,0
1,-2.9,GO:0010633,negative regulation of epithelial cell migration,M1,1,0
1,-5.7,R-HSA-9658195,Leishmania infection,M1,1,0
1,-3.1,M17,PID NOTCH PATHWAY,M1,1,0
1,-3.3,WP4357,NRF2-ARE regulation,M1,1,0
1,-2.3,GO:0009408,response to heat,M1,1,0
1,-2,GO:0001936,regulation of endothelial cell proliferation,M1,1,0
1,-7.5,GDP01389,Colorectal Neoplasms,M1,1,0
1,-2,GDP01598,Congenital Pectus Excavatum,M1,1,0
1,-4.2,hsa04144,Endocytosis,M1,1,0
1,-4.1,GO:0017015,regulation of transforming growth factor beta receptor signaling pathway,M1,1,0
1,-9.1,GDP02043,Diabetes,M1,1,0
1,-3.1,GDP05688,Peripheral arterial stenosis,M1,1,0
1,-2.9,hsa04714,Thermogenesis,M1,1,0
1,-6.9,GO:0007346,regulation of mitotic cell cycle,M1,1,0
1,-5,GO:0072593,reactive oxygen species metabolic process,M1,1,0
1,-4.6,GO:0045471,response to ethanol,M1,1,0
1,-2.7,R-HSA-9675126,Diseases of mitotic cell cycle,M1,1,0
1,-6.1,GO:0006351,DNA-templated transcription,M1,1,0
1,-3.4,GO:0044000,movement in host,M1,1,0
1,-10,GO:0043410,positive regulation of MAPK cascade,M1,1,0
1,-3.8,GO:0002029,desensitization of G protein-coupled receptor signaling pathway,M1,1,0
1,-2.7,hsa04114,Oocyte meiosis,M1,1,0
1,-3.5,GDP00355,Alzheimer disease,M1,1,0
1,-3.5,GDP02808,Giant Cell Glioblastoma,M1,1,0
1,-3.1,GO:0032233,positive regulation of actin filament bundle assembly,M1,1,0
1,-3.8,GDP00636,Autism,M1,1,0
1,-5,GO:0009749,response to glucose,M1,1,0
1,-2.5,GO:0032735,positive regulation of interleukin-12 production,M1,1,0
1,-8.8,hsa04510,Focal adhesion,M1,1,0
1,-4.5,hsa04926,Relaxin signaling pathway,M1,1,0
1,-5.5,R-HSA-195721,Signaling by WNT,M1,1,0
1,-2.3,GO:0034332,adherens junction organization,M1,1,0
1,-6.4,GDP06858,Subcutaneous lipoma,M1,1,0
1,-4.8,GO:0050808,synapse organization,M1,1,0
1,-2.7,GO:0033144,negative regulation of intracellular steroid hormone receptor signaling pathway,M1,1,0
1,-6.3,hsa04024,cAMP signaling pathway,M1,1,0
1,-2.9,WP4838,Regucalcin in proximal tubule epithelial kidney cells,M1,1,0
1,-2.7,GO:0032411,positive regulation of transporter activity,M1,1,0
1,-3.9,GO:0032496,response to lipopolysaccharide,M1,1,0
1,-2.7,hsa04728,Dopaminergic synapse,M1,1,0
1,-3.2,GO:0030512,negative regulation of transforming growth factor beta receptor signaling pathway,M1,1,0
1,-3.3,GO:2000772,regulation of cellular senescence,M1,1,0
1,-2.6,GO:0007595,lactation,M1,1,0
1,-12,WP4659,Gastrin signaling pathway,M1,1,0
1,-8.7,GO:1901654,response to ketone,M1,1,0
1,-3,GO:0051339,regulation of lyase activity,M1,1,0
1,-5.9,R-HSA-1296025,ATP sensitive Potassium channels,M1,1,0
1,-4.2,GO:0001654,eye development,M1,1,0
1,-4.5,GO:0008361,regulation of cell size,M1,1,0
1,-2.6,M62,PID EPHB FWD PATHWAY,M1,1,0
1,-5.5,WP4754,IL-18 signaling pathway,M1,1,0
1,-6.1,GO:0050714,positive regulation of protein secretion,M1,1,0
1,-2.8,GO:0032944,regulation of mononuclear cell proliferation,M1,1,0
1,-7.5,GO:0007517,muscle organ development,M1,1,0
1,-2.2,GO:1903170,negative regulation of calcium ion transmembrane transport,M1,1,0
1,-4.9,GO:0030501,positive regulation of bone mineralization,M1,1,0
1,-4.5,GO:1902895,positive regulation of miRNA transcription,M1,1,0
1,-5.2,GDP00547,Arthritis,M1,1,0
1,-2.4,hsa04658,Th1 and Th2 cell differentiation,M1,1,0
1,-2.5,GO:1901215,negative regulation of neuron death,M1,1,0
1,-8.9,WP306,Focal adhesion,M1,1,0
1,-6.8,R-HSA-9006936,Signaling by TGFB family members,M1,1,0
1,-2.4,GO:0030509,BMP signaling pathway,M1,1,0
1,-5.3,R-HSA-202131,Metabolism of nitric oxide: NOS3 activation and regulation,M1,1,0
1,-9.7,GO:1903532,positive regulation of secretion by cell,M1,1,0
1,-4,GO:0048592,eye morphogenesis,M1,1,0
1,-4.9,GO:0034763,negative regulation of transmembrane transport,M1,1,0
1,-7.2,GDP04202,Lung Cancer,M1,1,0
1,-3.9,GO:2000060,positive regulation of ubiquitin-dependent protein catabolic process,M1,1,0
1,-3.1,GO:0043407,negative regulation of MAP kinase activity,M1,1,0
1,-4.5,GO:0070169,positive regulation of biomineral tissue development,M1,1,0
1,-3.3,GO:1901615,organic hydroxy compound metabolic process,M1,1,0
1,-4.4,R-HSA-3700989,Transcriptional Regulation by TP53,M1,1,0
1,-3.8,GO:0008630,intrinsic apoptotic signaling pathway in response to DNA damage,M1,1,0
1,-2.4,GO:0060021,roof of mouth development,M1,1,0
1,-5.5,GO:0031647,regulation of protein stability,M1,1,0
1,-3.7,GO:0010827,regulation of glucose transmembrane transport,M1,1,0
1,-2.8,hsa04611,Platelet activation,M1,1,0
1,-4.5,R-HSA-201681,TCF dependent signaling in response to WNT,M1,1,0
1,-6.3,GO:0007179,transforming growth factor beta receptor signaling pathway,M1,1,0
1,-2.2,WP5097,CCL18 signaling pathway,M1,1,0
1,-3.2,GO:0032940,secretion by cell,M1,1,0
1,-4.2,GO:0048813,dendrite morphogenesis,M1,1,0
1,-9.3,GO:0001568,blood vessel development,M1,1,0
1,-2.5,GO:0060191,regulation of lipase activity,M1,1,0
1,-4.3,GDP05535,Papilloma,M1,1,0
1,-4.3,WP5083,Neuroinflammation and glutamatergic signaling,M1,1,0
1,-3.1,R-HSA-9013406,RHOQ GTPase cycle,M1,1,0
1,-2.1,R-HSA-4086398,Ca2+ pathway,M1,1,0
1,-2.7,GO:0023061,signal release,M1,1,0
1,-2.6,GO:0001667,ameboidal-type cell migration,M1,1,0
1,-5.4,WP4746,Thyroid hormones production and peripheral downstream signaling effects,M1,1,0
1,-4.3,M166,PID ATF2 PATHWAY,M1,1,0
1,-2.4,WP1772,Apoptosis modulation and signaling,M1,1,0
1,-3.6,R-HSA-445355,Smooth Muscle Contraction,M1,1,0
1,-2.7,GO:0035850,epithelial cell differentiation involved in kidney development,M1,1,0
1,-2.6,GDP02826,"Glaucoma, congenital",M1,1,0
1,-4.3,CORUM:5177,"Polycystin-1 multiprotein complex (ACTN1, CDH1, SRC, JUP, VCL, CTNNB1, PXN, BCAR1, PKD1, PTK2, TLN1)",M1,1,0
1,-4.4,M99,PID TXA2PATHWAY,M1,1,0
1,-3.7,M91,PID TCPTP PATHWAY,M1,1,0
1,-3.5,R-HSA-2454202,Fc epsilon receptor (FCERI) signaling,M1,1,0
1,-4.2,GO:0097306,cellular response to alcohol,M1,1,0
1,-7.1,GO:1903050,regulation of proteolysis involved in protein catabolic process,M1,1,0
1,-4.5,WP5316,Primary ovarian insufficiency,M1,1,0
1,-4.4,GO:0072006,nephron development,M1,1,0
1,-5,GO:0031623,receptor internalization,M1,1,0
1,-3.1,GDP05387,Osteoarthritis Of Hip,M1,1,0
1,-3.9,GO:0016358,dendrite development,M1,1,0
1,-3.2,GO:0033209,tumor necrosis factor-mediated signaling pathway,M1,1,0
1,-2.3,WP75,Toll-like receptor signaling pathway,M1,1,0
1,-7.6,GO:0046903,secretion,M1,1,0
1,-9.9,GO:0010959,regulation of metal ion transport,M1,1,0
1,-3.9,GO:0099173,postsynapse organization,M1,1,0
1,-4.3,GO:2000649,regulation of sodium ion transmembrane transporter activity,M1,1,0
1,-9.1,hsa04152,AMPK signaling pathway,M1,1,0
1,-2.7,WP3850,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling,M1,1,0
1,-3.5,R-HSA-1483255,PI Metabolism,M1,1,0
1,-3,GO:0032414,positive regulation of ion transmembrane transporter activity,M1,1,0
1,-3.6,R-HSA-74752,Signaling by Insulin receptor,M1,1,0
1,-4.4,GO:0002237,response to molecule of bacterial origin,M1,1,0
1,-2.4,GDP01822,Crohn Disease,M1,1,0
1,-5.6,GO:0071214,cellular response to abiotic stimulus,M1,1,0
1,-12,GO:1901699,cellular response to nitrogen compound,M1,1,0
1,-3.2,GO:0001505,regulation of neurotransmitter levels,M1,1,0
1,-6,R-HSA-5653656,Vesicle-mediated transport,M1,1,0
1,-6,WP1541,Energy metabolism,M1,1,0
1,-3.5,GDP04737,Monogenic Diabetes,M1,1,0
1,-4.2,M7,PID FCER1 PATHWAY,M1,1,0
1,-2.7,hsa05216,Thyroid cancer,M1,1,0
1,-4.2,GO:0045598,regulation of fat cell differentiation,M1,1,0
1,-4.1,GO:0060538,skeletal muscle organ development,M1,1,0
1,-6.7,GO:0098657,import into cell,M1,1,0
1,-4.7,GO:0009612,response to mechanical stimulus,M1,1,0
1,-7.8,GO:0001952,regulation of cell-matrix adhesion,M1,1,0
1,-2.1,GO:1904035,regulation of epithelial cell apoptotic process,M1,1,0
1,-4.3,hsa05162,Measles,M1,1,0
1,-2.2,GO:0001706,endoderm formation,M1,1,0
1,-2.7,R-HSA-1500931,Cell-Cell communication,M1,1,0
1,-4.2,GO:0099175,regulation of postsynapse organization,M1,1,0
1,-9,GO:0071396,cellular response to lipid,M1,1,0
1,-8.1,hsa04810,Regulation of actin cytoskeleton,M1,1,0
1,-2,R-HSA-375165,NCAM signaling for neurite out-growth,M1,1,0
1,-3,hsa04725,Cholinergic synapse,M1,1,0
1,-4.4,GO:0032941,secretion by tissue,M1,1,0
1,-2.5,GO:0010171,body morphogenesis,M1,1,0
1,-3,GDP05058,Nervous System Diseases,M1,1,0
1,-3.8,GO:0002833,positive regulation of response to biotic stimulus,M1,1,0
1,-4.5,GO:0045778,positive regulation of ossification,M1,1,0
1,-7,GO:0014706,striated muscle tissue development,M1,1,0
1,-7.2,GO:0071496,cellular response to external stimulus,M1,1,0
1,-10,GO:0071407,cellular response to organic cyclic compound,M1,1,0
1,-4.7,GO:0051091,positive regulation of DNA-binding transcription factor activity,M1,1,0
1,-4.4,GDP02837,Glomerular Hyalinosis,M1,1,0
1,-6.2,GO:0043271,negative regulation of monoatomic ion transport,M1,1,0
1,-17,GDP05999,Prostatic Neoplasms,M1,1,0
1,-5.3,GO:0050920,regulation of chemotaxis,M1,1,0
1,-3.7,GDP06079,Pulmonary arterial hypertension,M1,1,0
1,-8.6,GO:0042698,ovulation cycle,M1,1,0
1,-7.6,WP236,Adipogenesis,M1,1,0
1,-3.2,GDP07240,Urinary bladder cancer,M1,1,0
1,-9.6,GO:0018193,peptidyl-amino acid modification,M1,1,0
1,-2.4,GO:2001257,regulation of cation channel activity,M1,1,0
1,-2.5,R-HSA-3769402,Deactivation of the beta-catenin transactivating complex,M1,1,0
1,-4.3,hsa04910,Insulin signaling pathway,M1,1,0
1,-2.4,GO:0030195,negative regulation of blood coagulation,M1,1,0
1,-2,GO:1901800,positive regulation of proteasomal protein catabolic process,M1,1,0
1,-3.3,GO:0042063,gliogenesis,M1,1,0
1,-4.8,GO:0000165,MAPK cascade,M1,1,0
1,-10,M124,PID CXCR4 PATHWAY,M1,1,0
1,-10,GO:0006816,calcium ion transport,M1,1,0
1,-3.4,GO:0072073,kidney epithelium development,M1,1,0
1,-5.8,GO:1903320,regulation of protein modification by small protein conjugation or removal,M1,1,0
1,-2.9,GO:0033688,regulation of osteoblast proliferation,M1,1,0
1,-2.1,GO:0048259,regulation of receptor-mediated endocytosis,M1,1,0
1,-2.9,GO:0031348,negative regulation of defense response,M1,1,0
1,-4.2,WP2853,Endoderm differentiation,M1,1,0
1,-4.1,GO:0031644,regulation of nervous system process,M1,1,0
1,-14,GO:0051347,positive regulation of transferase activity,M1,1,0
1,-8.6,hsa04310,Wnt signaling pathway,M1,1,0
1,-6.2,GO:0022612,gland morphogenesis,M1,1,0
1,-3.8,hsa05214,Glioma,M1,1,0
1,-3.8,R-HSA-9824439,Bacterial Infection Pathways,M1,1,0
1,-6.4,GO:0043551,regulation of phosphatidylinositol 3-kinase activity,M1,1,0
1,-2.1,GO:0008544,epidermis development,M1,1,0
1,-2.3,WP286,IL-3 signaling pathway,M1,1,0
1,-3.3,GO:0061440,kidney vasculature development,M1,1,0
1,-5.5,hsa05410,Hypertrophic cardiomyopathy,M1,1,0
1,-6.8,GO:0010632,regulation of epithelial cell migration,M1,1,0
1,-3.9,hsa04920,Adipocytokine signaling pathway,M1,1,0
1,-2,M8,PID ENDOTHELIN PATHWAY,M1,1,0
1,-3.5,GO:0032370,positive regulation of lipid transport,M1,1,0
1,-2,GO:0051445,regulation of meiotic cell cycle,M1,1,0
1,-3.1,GO:0043954,cellular component maintenance,M1,1,0
1,-2.5,GO:0035148,tube formation,M1,1,0
1,-4.7,GO:0042060,wound healing,M1,1,0
1,-2,GO:0009306,protein secretion,M1,1,0
1,-5,GO:0043266,regulation of potassium ion transport,M1,1,0
1,-4.2,hsa05132,Salmonella infection,M1,1,0
1,-2.8,GDP03754,Intracranial Neoplasm,M1,1,0
1,-3,GO:0070633,transepithelial transport,M1,1,0
1,-2.6,hsa04210,Apoptosis,M1,1,0
1,-2.8,GO:1905952,regulation of lipid localization,M1,1,0
1,-4.4,WP2643,Nanoparticle-mediated activation of receptor signaling,M1,1,0
1,-4.3,GDP00891,Brain Neoplasms,M1,1,0
1,-4.5,GO:0030003,intracellular monoatomic cation homeostasis,M1,1,0
1,-2.2,hsa04620,Toll-like receptor signaling pathway,M1,1,0
1,-2.3,GO:0000041,transition metal ion transport,M1,1,0
1,-2.6,GO:0045445,myoblast differentiation,M1,1,0
1,-2.2,R-HSA-9725370,Signaling by ALK fusions and activated point mutants,M1,1,0
1,-3.8,GDP01016,Camptodactyly of fingers,M1,1,0
1,-2.7,R-HSA-9607240,FLT3 Signaling,M1,1,0
1,-5.9,GO:0038094,Fc-gamma receptor signaling pathway,M1,1,0
1,-3.4,GO:0007263,nitric oxide mediated signal transduction,M1,1,0
1,-13,GO:0051223,regulation of protein transport,M1,1,0
1,-2.3,GDP05112,Neurodevelopmental Disorders,M1,1,0
1,-4.1,R-HSA-389356,CD28 co-stimulation,M1,1,0
1,-2.3,GDP00518,Arachnodactyly,M1,1,0
1,-3.3,hsa04070,Phosphatidylinositol signaling system,M1,1,0
1,-4.5,GDP06451,Scoliosis,M1,1,0
1,-4,GDP02052,Diabetic Amyotrophy,M1,1,0
1,-6.6,WP3929,Chemokine signaling pathway,M1,1,0
1,-5.3,GO:0046887,positive regulation of hormone secretion,M1,1,0
1,-4.9,GO:0045807,positive regulation of endocytosis,M1,1,0
1,-7.3,GDP02058,Diabetic Nephropathy,M1,1,0
1,-2.4,GO:0003254,regulation of membrane depolarization,M1,1,0
1,-3.7,R-HSA-9661069,"Defective binding of RB1 mutants to E2F1,(E2F2, E2F3)",M1,1,0
1,-11,GO:0048732,gland development,M1,1,0
1,-4.5,R-HSA-199991,Membrane Trafficking,M1,1,0
1,-3.1,GO:0010638,positive regulation of organelle organization,M1,1,0
1,-2.5,GO:0032434,regulation of proteasomal ubiquitin-dependent protein catabolic process,M1,1,0
1,-4.7,hsa04919,Thyroid hormone signaling pathway,M1,1,0
1,-9.1,GDP02994,Heart Failure,M1,1,0
1,-5.7,GO:1903522,regulation of blood circulation,M1,1,0
1,-4.5,GO:0055080,monoatomic cation homeostasis,M1,1,0
1,-2.7,GDP04143,Lipoatrophy,M1,1,0
1,-2.5,GDP06403,Sarcoma,M1,1,0
1,-5.1,GO:0007044,cell-substrate junction assembly,M1,1,0
1,-4,GO:0071383,cellular response to steroid hormone stimulus,M1,1,0
1,-8.3,GO:0042176,regulation of protein catabolic process,M1,1,0
1,-10,GO:0071560,cellular response to transforming growth factor beta stimulus,M1,1,0
1,-4.8,GO:1904029,regulation of cyclin-dependent protein kinase activity,M1,1,0
1,-7,GO:0030308,negative regulation of cell growth,M1,1,0
1,-3.6,GO:0046928,regulation of neurotransmitter secretion,M1,1,0
1,-5.3,WP4258,lncRNA in canonical Wnt signaling and colorectal cancer,M1,1,0
1,-12,WP5087,Malignant pleural mesothelioma,M1,1,0
1,-2.8,WP4950,16p11.2 distal deletion syndrome,M1,1,0
1,-7.1,GO:0062197,cellular response to chemical stress,M1,1,0
1,-3.3,GO:0006883,intracellular sodium ion homeostasis,M1,1,0
1,-6.3,GO:0042692,muscle cell differentiation,M1,1,0
1,-2.4,GDP06904,Syndactyly,M1,1,0
1,-2.5,GO:0046849,bone remodeling,M1,1,0
1,-3,GO:0048705,skeletal system morphogenesis,M1,1,0
1,-3.3,GO:0048260,positive regulation of receptor-mediated endocytosis,M1,1,0
1,-4.1,WP2881,Estrogen receptor pathway,M1,1,0
1,-4.3,R-HSA-2173795,Downregulation of SMAD2/3:SMAD4 transcriptional activity,M1,1,0
1,-6.3,R-HSA-9634638,Estrogen-dependent nuclear events downstream of ESR-membrane signaling,M1,1,0
1,-5.4,hsa04520,Adherens junction,M1,1,0
1,-3.2,GDP06484,Senile Dementia,M1,1,0
1,-4,GDP02054,Diabetic Autonomic Neuropathy,M1,1,0
1,-6.3,WP2059,Alzheimer's disease and miRNA effects,M1,1,0
1,-2.9,GO:0051235,maintenance of location,M1,1,0
1,-3.6,GO:1904407,positive regulation of nitric oxide metabolic process,M1,1,0
1,-2.2,GO:0009409,response to cold,M1,1,0
1,-2.9,GO:0022037,metencephalon development,M1,1,0
1,-2.9,GO:0018107,peptidyl-threonine phosphorylation,M1,1,0
1,-3.5,GO:0032495,response to muramyl dipeptide,M1,1,0
1,-4.7,M142,PID AJDISS 2PATHWAY,M1,1,0
1,-10,hsa05222,Small cell lung cancer,M1,1,0
1,-6.1,GO:0003015,heart process,M1,1,0
1,-2.8,GO:0001838,embryonic epithelial tube formation,M1,1,0
1,-3.6,M2,PID SMAD2 3NUCLEAR PATHWAY,M1,1,0
1,-8.8,GDP04398,Mammary Neoplasms,M1,1,0
1,-6.2,GO:0030002,intracellular monoatomic anion homeostasis,M1,1,0
1,-3.7,R-HSA-9659787,Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects,M1,1,0
1,-4.1,GO:0080164,regulation of nitric oxide metabolic process,M1,1,0
1,-3.8,GO:0060048,cardiac muscle contraction,M1,1,0
1,-3.4,GO:0001843,neural tube closure,M1,1,0
1,-4,GDP02063,Diabetic polyneuropathy,M1,1,0
1,-5.8,GO:0002253,activation of immune response,M1,1,0
1,-3,GO:1901017,negative regulation of potassium ion transmembrane transporter activity,M1,1,0
1,-3.7,M174,PID UPA UPAR PATHWAY,M1,1,0
1,-2.3,GO:0010543,regulation of platelet activation,M1,1,0
1,-2.8,GO:0043627,response to estrogen,M1,1,0
1,-4.4,GO:0043409,negative regulation of MAPK cascade,M1,1,0
1,-5.3,hsa01522,Endocrine resistance,M1,1,0
1,-2.8,GO:1901797,negative regulation of signal transduction by p53 class mediator,M1,1,0
1,-3.1,GO:0032868,response to insulin,M1,1,0
1,-2.8,GO:0048863,stem cell differentiation,M1,1,0
1,-2.5,GDP04467,Medullomyoblastoma,M1,1,0
1,-2,GO:0031398,positive regulation of protein ubiquitination,M1,1,0
1,-4,GO:0031099,regeneration,M1,1,0
1,-4.9,GO:0008202,steroid metabolic process,M1,1,0
1,-3.2,GO:0033233,regulation of protein sumoylation,M1,1,0
1,-3.1,GO:0051961,negative regulation of nervous system development,M1,1,0
1,-2.3,GO:0050819,negative regulation of coagulation,M1,1,0
1,-4,GDP00579,Asymmetric Diabetic Proximal Motor Neuropathy,M1,1,0
1,-3.2,GO:0051592,response to calcium ion,M1,1,0
1,-4.5,M5493,WNT SIGNALING,M1,1,0
1,-6.2,WP2572,Primary focal segmental glomerulosclerosis (FSGS),M1,1,0
1,-4.4,GO:0045995,regulation of embryonic development,M1,1,0
1,-4.9,hsa04390,Hippo signaling pathway,M1,1,0
1,-3.7,GO:0022401,negative adaptation of signaling pathway,M1,1,0
1,-2.4,GO:0090407,organophosphate biosynthetic process,M1,1,0
1,-5.8,R-HSA-397014,Muscle contraction,M1,1,0
1,-5.6,GO:0104004,cellular response to environmental stimulus,M1,1,0
1,-4.9,GO:0045786,negative regulation of cell cycle,M1,1,0
1,-6.5,GO:0055081,monoatomic anion homeostasis,M1,1,0
1,-3.9,M65,PID FRA PATHWAY,M1,1,0
1,-2.4,GO:0042149,cellular response to glucose starvation,M1,1,0
1,-5.2,GO:0006109,regulation of carbohydrate metabolic process,M1,1,0
1,-3,GO:0010517,regulation of phospholipase activity,M1,1,0
1,-5.3,R-HSA-8878159,Transcriptional regulation by RUNX3,M1,1,0
1,-2.2,R-HSA-166166,MyD88-independent TLR4 cascade,M1,1,0
1,-2.6,R-HSA-8853884,Transcriptional Regulation by VENTX,M1,1,0
1,-3,R-HSA-373755,Semaphorin interactions,M1,1,0
1,-4.4,GO:0051048,negative regulation of secretion,M1,1,0
1,-3.5,GO:0007204,positive regulation of cytosolic calcium ion concentration,M1,1,0
1,-2.2,GO:0008543,fibroblast growth factor receptor signaling pathway,M1,1,0
1,-4,GO:0000278,mitotic cell cycle,M1,1,0
1,-2,GDP05340,Optic Atrophy,M1,1,0
1,-2.4,R-HSA-9013148,CDC42 GTPase cycle,M1,1,0
1,-2.6,GO:1903115,regulation of actin filament-based movement,M1,1,0
1,-2.6,R-HSA-425366,"Transport of bile salts and organic acids, metal ions and amine compounds",M1,1,0
1,-5.1,GO:0061337,cardiac conduction,M1,1,0
1,-5.6,GO:0032835,glomerulus development,M1,1,0
1,-6.4,GDP00808,Bipolar Disorder,M1,1,0
1,-4.6,R-HSA-6802957,Oncogenic MAPK signaling,M1,1,0
1,-3.7,GO:0055074,calcium ion homeostasis,M1,1,0
1,-2.1,GDP03492,Hypoplasia of the maxilla,M1,1,0
1,-12,GO:0071417,cellular response to organonitrogen compound,M1,1,0
1,-4.3,GDP00480,Aortic Aneurysm,M1,1,0
1,-2.3,GDP00527,Arnold-Chiari malformation,M1,1,0
1,-4,GDP01327,Cirrhosis,M1,1,0
1,-3.8,GO:0031960,response to corticosteroid,M1,1,0
1,-7.9,hsa04071,Sphingolipid signaling pathway,M1,1,0
1,-3.8,GDP00912,Breast Adenocarcinoma,M1,1,0
1,-2.7,WP4538,Regulatory circuits of the STAT3 signaling pathway,M1,1,0
1,-4.8,WP3931,Embryonic stem cell pluripotency pathways,M1,1,0
1,-2.4,GO:0071774,response to fibroblast growth factor,M1,1,0
1,-2.6,GO:0022405,hair cycle process,M1,1,0
1,-4.4,M252,PID IL8 CXCR1 PATHWAY,M1,1,0
1,-2.4,GDP03299,Hypercholesterolemia,M1,1,0
1,-7.5,WP4008,NO/cGMP/PKG mediated neuroprotection,M1,1,0
1,-7.6,GDP00870,Brachydactyly,M1,1,0
1,-4,GDP06896,Symmetric Diabetic Proximal Motor Neuropathy,M1,1,0
1,-2.8,GO:0050818,regulation of coagulation,M1,1,0
1,-5,GO:0051345,positive regulation of hydrolase activity,M1,1,0
1,-2.4,GO:0042633,hair cycle,M1,1,0
1,-2.8,GO:0030324,lung development,M1,1,0
1,-2.1,GO:0042246,tissue regeneration,M1,1,0
1,-4.8,GO:0050709,negative regulation of protein secretion,M1,1,0
1,-3.4,R-HSA-2262752,Cellular responses to stress,M1,1,0
1,-2.8,GO:0018105,peptidyl-serine phosphorylation,M1,1,0
1,-9.2,WP2877,Vitamin D receptor pathway,M1,1,0
1,-3.2,GDP06058,Ptosis,M1,1,0
1,-3.4,M220,PID CASPASE PATHWAY,M1,1,0
1,-11,hsa05215,Prostate cancer,M1,1,0
1,-4.2,R-HSA-4641262,Disassembly of the destruction complex and recruitment of AXIN to the membrane,M1,1,0
1,-2.7,GO:1902652,secondary alcohol metabolic process,M1,1,0
1,-3.4,GO:0043491,protein kinase B signaling,M1,1,0
1,-2.4,GO:1900047,negative regulation of hemostasis,M1,1,0
1,-5.6,WP3414,Initiation of transcription and translation elongation at the HIV-1 LTR,M1,1,0
1,-4.1,WP313,Hepatocyte growth factor receptor signaling,M1,1,0
1,-2,GO:1902107,positive regulation of leukocyte differentiation,M1,1,0
1,-3.1,GDP04916,Myoclonic Seizures,M1,1,0
1,-3.6,GO:0050807,regulation of synapse organization,M1,1,0
1,-2.4,R-HSA-6802946,Signaling by moderate kinase activity BRAF mutants,M1,1,0
1,-8.8,GO:0050796,regulation of insulin secretion,M1,1,0
1,-2.8,hsa04137,Mitophagy - animal,M1,1,0
1,-3.1,GO:0061387,regulation of extent of cell growth,M1,1,0
1,-4.2,M165,PID SYNDECAN 4 PATHWAY,M1,1,0
1,-3.3,GO:0007405,neuroblast proliferation,M1,1,0
1,-11,GDP04358,Malignant Neoplasm,M1,1,0
1,-2.7,GDP03419,Hypodontia,M1,1,0
1,-2.2,WP2864,Apoptosis-related network due to altered Notch3 in ovarian cancer,M1,1,0
1,-4,GDP02057,Diabetic Mononeuropathy,M1,1,0
1,-4.1,hsa05415,Diabetic cardiomyopathy,M1,1,0
1,-3.4,GDP00576,Asthma,M1,1,0
1,-2.2,GO:0071320,cellular response to cAMP,M1,1,0
1,-3.5,GDP06073,Pulmonary Hypertension,M1,1,0
1,-2.7,GDP04209,Lung carcinoma,M1,1,0
1,-3.2,GO:0052547,regulation of peptidase activity,M1,1,0
1,-2.4,GO:0006638,neutral lipid metabolic process,M1,1,0
1,-5.4,GO:0099536,synaptic signaling,M1,1,0
1,-2.8,GO:0043500,muscle adaptation,M1,1,0
1,-3,GO:0031063,regulation of histone deacetylation,M1,1,0
1,-3.7,GO:1902306,negative regulation of sodium ion transmembrane transport,M1,1,0
1,-2.4,WP2038,Microtubule cytoskeleton regulation,M1,1,0
1,-3.7,WP2037,Prolactin signaling pathway,M1,1,0
1,-2.2,GO:0051155,positive regulation of striated muscle cell differentiation,M1,1,0
1,-3.3,GO:0051384,response to glucocorticoid,M1,1,0
1,-8.9,GO:0016055,Wnt signaling pathway,M1,1,0
1,-2,GO:0044091,membrane biogenesis,M1,1,0
1,-2.3,R-HSA-373752,Netrin-1 signaling,M1,1,0
1,-3.6,GDP02896,Gout,M1,1,0
1,-5.2,GO:0002831,regulation of response to biotic stimulus,M1,1,0
1,-3.3,GDP07133,Transient Ischemic Attack,M1,1,0
1,-3.2,GO:0051043,regulation of membrane protein ectodomain proteolysis,M1,1,0
1,-9.1,WP2355,Corticotropin-releasing hormone signaling pathway,M1,1,0
1,-2.1,GO:0048678,response to axon injury,M1,1,0
1,-3.5,GO:0010544,negative regulation of platelet activation,M1,1,0
1,-8.5,GO:0050878,regulation of body fluid levels,M1,1,0
1,-2.5,GO:0099504,synaptic vesicle cycle,M1,1,0
1,-2.3,GO:0051054,positive regulation of DNA metabolic process,M1,1,0
1,-5.6,GO:0043009,chordate embryonic development,M1,1,0
1,-7.8,GO:0051249,regulation of lymphocyte activation,M1,1,0
1,-2.5,GDP00319,Alopecia,M1,1,0
1,-3.2,GO:0030198,extracellular matrix organization,M1,1,0
1,-4.2,WP3863,T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection,M1,1,0
1,-4.1,M10,PID BCR 5PATHWAY,M1,1,0
1,-2.6,GDP01290,Choreoathetosis,M1,1,0
1,-3.9,GDP01507,Congenital Exomphalos,M1,1,0
1,-6.3,WP185,Integrin-mediated cell adhesion,M1,1,0
1,-4.1,GO:0062013,positive regulation of small molecule metabolic process,M1,1,0
1,-3.2,GO:0099172,presynapse organization,M1,1,0
1,-2.9,GO:0002862,negative regulation of inflammatory response to antigenic stimulus,M1,1,0
1,-4.1,GDP04464,Medulloblastoma,M1,1,0
1,-4.9,R-HSA-3899300,SUMOylation of transcription cofactors,M1,1,0
1,-2.5,GO:0010828,positive regulation of glucose transmembrane transport,M1,1,0
1,-9.9,GO:0051251,positive regulation of lymphocyte activation,M1,1,0
1,-3.4,M67,PID ARF6 TRAFFICKING PATHWAY,M1,1,0
1,-3.9,GO:0030900,forebrain development,M1,1,0
1,-27,GO:0003013,circulatory system process,M1,1,0
1,-15,GO:0030001,metal ion transport,M1,1,0
1,-3.5,GO:0001889,liver development,M1,1,0
1,-3.2,GO:0006706,steroid catabolic process,M1,1,0
1,-2.8,GO:1905207,regulation of cardiocyte differentiation,M1,1,0
1,-4.8,GO:0002009,morphogenesis of an epithelium,M1,1,0
1,-5.4,GO:0009792,embryo development ending in birth or egg hatching,M1,1,0
1,-4.5,GO:0032413,negative regulation of ion transmembrane transporter activity,M1,1,0
1,-9.8,hsa05205,Proteoglycans in cancer,M1,1,0
1,-4.7,GO:2000629,negative regulation of miRNA metabolic process,M1,1,0
1,-4,GO:0042593,glucose homeostasis,M1,1,0
1,-2.6,GO:0048754,branching morphogenesis of an epithelial tube,M1,1,0
1,-4.2,GDP00303,Alcoholic Liver Cirrhosis,M1,1,0
1,-2.8,GO:1900046,regulation of hemostasis,M1,1,0
1,-2.7,R-HSA-9013407,RHOH GTPase cycle,M1,1,0
1,-2.2,GO:0043124,negative regulation of I-kappaB kinase/NF-kappaB signaling,M1,1,0
1,-5.7,GO:0070372,regulation of ERK1 and ERK2 cascade,M1,1,0
1,-2.2,M278,PID RAC1 PATHWAY,M1,1,0
1,-3.1,GO:2001057,reactive nitrogen species metabolic process,M1,1,0
1,-2.2,GO:0010332,response to gamma radiation,M1,1,0
1,-3.8,GO:0032410,negative regulation of transporter activity,M1,1,0
1,-5,hsa04115,p53 signaling pathway,M1,1,0
1,-2.5,GO:1900274,regulation of phospholipase C activity,M1,1,0
1,-2.8,GO:0031349,positive regulation of defense response,M1,1,0
1,-2.9,GO:0030193,regulation of blood coagulation,M1,1,0
1,-3.1,GO:0090398,cellular senescence,M1,1,0
1,-4.3,GO:0016032,viral process,M1,1,0
1,-7.4,GO:0045936,negative regulation of phosphate metabolic process,M1,1,0
1,-3.5,R-HSA-9669938,Signaling by KIT in disease,M1,1,0
1,-3.3,GO:0014020,primary neural tube formation,M1,1,0
1,-2.2,GO:0046661,male sex differentiation,M1,1,0
1,-4,GO:1903844,regulation of cellular response to transforming growth factor beta stimulus,M1,1,0
1,-2.2,GDP03519,Hypotonia,M1,1,0
1,-2.1,GO:0001819,positive regulation of cytokine production,M1,1,0
1,-3,GDP04312,Macroglossia,M1,1,0
1,-9,GO:0043434,response to peptide hormone,M1,1,0
1,-2.8,GO:0048010,vascular endothelial growth factor receptor signaling pathway,M1,1,0
1,-13,GO:0044057,regulation of system process,M1,1,0
1,-2.7,GDP07300,Ventricular tachycardia,M1,1,0
1,-2.3,GO:0090132,epithelium migration,M1,1,0
1,-6.3,GO:0046545,development of primary female sexual characteristics,M1,1,0
1,-4.7,WP3981,miRNA regulation of prostate cancer signaling pathways,M1,1,0
1,-2,GO:0046034,ATP metabolic process,M1,1,0
1,-2.7,GDP00230,Adenoma,M1,1,0
1,-2.1,GO:0055008,cardiac muscle tissue morphogenesis,M1,1,0
1,-3.5,R-HSA-9707616,Heme signaling,M1,1,0
1,-2.5,GDP02824,Glaucoma,M1,1,0
1,-2.6,R-HSA-8853659,RET signaling,M1,1,0
1,-4.8,R-HSA-2173789,TGF-beta receptor signaling activates SMADs,M1,1,0
1,-2.7,WP1471,Target of rapamycin signaling,M1,1,0
1,-2.6,R-HSA-195253,Degradation of beta-catenin by the destruction complex,M1,1,0
1,-2.1,GDP00314,Allergic rhinitis,M1,1,0
1,-3.9,GO:0035641,locomotory exploration behavior,M1,1,0
1,-5.9,hsa04934,Cushing syndrome,M1,1,0
1,-2.2,GO:0051656,establishment of organelle localization,M1,1,0
1,-7.4,GO:0061045,negative regulation of wound healing,M1,1,0
1,-5.6,R-HSA-372708,p130Cas linkage to MAPK signaling for integrins,M1,1,0
1,-7.1,GO:0001933,negative regulation of protein phosphorylation,M1,1,0
1,-2.1,GO:0035306,positive regulation of dephosphorylation,M1,1,0
1,-4.3,M140,PID RANBP2 PATHWAY,M1,1,0
1,-2.2,GO:0055088,lipid homeostasis,M1,1,0
1,-2.2,GDP05443,Ovarian cancer,M1,1,0
1,-2.8,GO:0071398,cellular response to fatty acid,M1,1,0
1,-5.5,GO:0050767,regulation of neurogenesis,M1,1,0
1,-6.3,hsa05165,Human papillomavirus infection,M1,1,0
1,-2.8,GO:1902253,regulation of intrinsic apoptotic signaling pathway by p53 class mediator,M1,1,0
1,-4.7,GO:0070665,positive regulation of leukocyte proliferation,M1,1,0
1,-3.1,WP4816,TGF-beta receptor signaling in skeletal dysplasias,M1,1,0
1,-3.7,GO:0031663,lipopolysaccharide-mediated signaling pathway,M1,1,0
1,-2.5,GO:0086003,cardiac muscle cell contraction,M1,1,0
